ONTOLOGY REPORT - ANNOTATIONS
| Term: | immune system process |
|
| Accession: | GO:0002376
|
browse the term
|
| Definition: | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| Comment: | Note that this term is a direct child of 'biological_process ; GO:0008150' because some immune system processes are types of cellular process (GO:0009987), whereas others are types of multicellular organism process (GO:0032501). This term was added by GO_REF:0000022. |
| Synonyms: | xref_analog: | Wikipedia:Immune_system |
|
|
immune system process
|
| G |
Ahr |
aryl hydrocarbon receptor |
|
|
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:1624291 |
RGD |
activation-induced cell death of T cells
|
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:1624291 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
IEA |
6 |
137,640,482 |
137,657,552 |
RGD:1600115 |
ENSEMBL |
| G |
Dnaja3 |
DnaJ (Hsp40) homolog, subfamily A, member 3 |
|
|
ISO |
10 |
10,984,721 |
11,009,374 |
RGD:1624291 |
RGD |
| G |
Dnaja3 |
DnaJ (Hsp40) homolog, subfamily A, member 3 |
|
|
IEA |
10 |
10,984,721 |
11,009,374 |
RGD:1600115 |
ENSEMBL |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
|
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:1624291 |
RGD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
|
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:1624291 |
RGD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
|
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:1624291 |
RGD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
|
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:1624291 |
RGD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
|
IEA |
17 |
78,050,491 |
78,097,802 |
RGD:1600115 |
ENSEMBL |
| G |
Rps6 |
ribosomal protein S6 |
|
|
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:1624291 |
RGD |
| G |
Siva1 |
SIVA1, apoptosis-inducing factor |
|
|
ISO |
6 |
137,631,408 |
137,635,724 |
RGD:1624291 |
RGD |
| G |
Siva1 |
SIVA1, apoptosis-inducing factor |
|
|
IEA |
6 |
137,631,408 |
137,635,724 |
RGD:1600115 |
ENSEMBL |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
|
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:1624291 |
RGD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
|
IEA |
13 |
102,718,703 |
102,818,768 |
RGD:1600115 |
ENSEMBL |
alpha-beta T cell activation involved in immune response
|
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:1624291 |
RGD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
IEA |
20 |
1,412,553 |
1,416,692 |
RGD:1600115 |
ENSEMBL |
antibody-dependent cellular cytotoxicity
|
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
|
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:1624291 |
RGD |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
|
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:1624291 |
RGD |
B cell affinity maturation
|
| G |
LOC688090 |
similar to RT1 class II histocompatibility antigen, B-1 beta chain precursor (RT1.B-beta(1)) |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
|
ISO |
20 |
4,730,559 |
4,736,201 |
RGD:1624291 |
RGD |
B cell cytokine production
|
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
|
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:1624291 |
RGD |
B cell homeostasis
|
| G |
Ahr |
aryl hydrocarbon receptor |
|
|
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:1624291 |
RGD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
|
ISO |
20 |
5,255,954 |
5,264,593 |
RGD:1624291 |
RGD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
|
ISO |
20 |
5,255,954 |
5,264,593 |
RGD:1624291 |
RGD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
|
IEA |
20 |
5,255,954 |
5,264,593 |
RGD:1600115 |
ENSEMBL |
| G |
Bax |
Bcl2-associated X protein |
|
|
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:1624291 |
RGD |
| G |
Bax |
Bcl2-associated X protein |
|
|
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:1624291 |
RGD |
| G |
Bax |
Bcl2-associated X protein |
|
|
IEA |
1 |
95,933,023 |
95,938,176 |
RGD:1600115 |
ENSEMBL |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
IEA |
13 |
12,730,736 |
12,905,108 |
RGD:1600115 |
ENSEMBL |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
|
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:1624291 |
RGD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
|
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:1624291 |
RGD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
|
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:1624291 |
RGD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
|
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:1624291 |
RGD |
| G |
Casp3 |
caspase 3 |
|
|
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:1624291 |
RGD |
| G |
Foxp3 |
forkhead box P3 |
|
|
ISO |
X |
26,950,006 |
26,965,329 |
RGD:1624291 |
RGD |
| G |
Foxp3 |
forkhead box P3 |
|
|
IBA |
X |
26,950,006 |
26,965,329 |
RGD:1600115 |
RefGenome |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
|
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:1624291 |
RGD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
|
IEA |
16 |
73,804,730 |
73,858,510 |
RGD:1600115 |
ENSEMBL |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
|
ISO |
X |
160,386,558 |
160,420,190 |
RGD:1624291 |
RGD |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
|
IEA |
X |
160,386,558 |
160,420,190 |
RGD:1600115 |
ENSEMBL |
| G |
Lilrb3 |
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 |
|
|
ISO |
1 |
63,651,983 |
63,659,834 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISS |
5 |
16,933,111 |
17,054,564 |
RGD:1600115 |
UniProtKB |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
|
ISO |
2 |
12,331,078 |
12,346,520 |
RGD:1624291 |
RGD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
|
ISS |
2 |
12,331,078 |
12,346,520 |
RGD:1600115 |
UniProtKB |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
|
IEA |
2 |
12,331,078 |
12,346,520 |
RGD:1600115 |
ENSEMBL |
| G |
Nckap1l |
NCK associated protein 1 like |
|
|
ISO |
7 |
142,351,954 |
142,397,045 |
RGD:1624291 |
RGD |
| G |
Nckap1l |
NCK associated protein 1 like |
|
|
IEA |
7 |
142,351,954 |
142,397,045 |
RGD:1600115 |
ENSEMBL |
| G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
|
ISO |
5 |
166,735,274 |
166,761,189 |
RGD:1624291 |
RGD |
| G |
Spns2 |
spinster homolog 2 |
|
|
ISO |
10 |
59,335,327 |
59,374,485 |
RGD:1624291 |
RGD |
| G |
Tnfrsf13b |
tumor necrosis factor receptor superfamily, member 13B |
|
|
ISO |
10 |
47,286,663 |
47,295,026 |
RGD:1624291 |
RGD |
| G |
Tnfrsf13b |
tumor necrosis factor receptor superfamily, member 13B |
|
|
IEA |
10 |
47,286,663 |
47,295,026 |
RGD:1600115 |
ENSEMBL |
| G |
Tnfrsf13c |
tumor necrosis factor receptor superfamily, member 13c |
|
|
ISO |
7 |
120,596,571 |
120,597,836 |
RGD:1624291 |
RGD |
| G |
Tnfsf13b |
tumor necrosis factor (ligand) superfamily, member 13b |
|
|
ISO |
16 |
84,837,266 |
84,856,103 |
RGD:1624291 |
RGD |
| G |
Tnfsf13b |
tumor necrosis factor (ligand) superfamily, member 13b |
|
|
IEA |
16 |
84,837,266 |
84,856,103 |
RGD:1600115 |
ENSEMBL |
B cell mediated immunity
|
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
|
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:1624291 |
RGD |
| G |
Lilrb3 |
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 |
|
|
ISO |
1 |
63,651,983 |
63,659,834 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
B cell proliferation involved in immune response
|
| G |
Cd180 |
CD180 molecule |
|
|
ISO |
2 |
33,609,034 |
33,621,585 |
RGD:1624291 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:1624291 |
RGD |
B-1 B cell homeostasis
|
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
|
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:1624291 |
RGD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
|
IEA |
6 |
96,419,024 |
96,463,891 |
RGD:1600115 |
ENSEMBL |
| G |
Sh2b2 |
SH2B adaptor protein 2 |
|
|
ISO |
12 |
21,544,434 |
21,572,232 |
RGD:1624291 |
RGD |
| G |
Sh2b2 |
SH2B adaptor protein 2 |
|
|
IEA |
12 |
21,544,434 |
21,572,232 |
RGD:1600115 |
ENSEMBL |
basophil degranulation
|
| G |
Pi4k2a |
phosphatidylinositol 4-kinase type 2 alpha |
|
|
IMP |
1 |
248,736,384 |
248,760,679 |
RGD:2306407 |
RGD |
CD8-positive, alpha-beta T cell differentiation involved in immune response
|
| G |
Eomes |
eomesodermin |
|
|
ISO |
8 |
123,376,689 |
123,383,451 |
RGD:1624291 |
RGD |
| G |
Eomes |
eomesodermin |
|
|
ISO |
8 |
123,376,689 |
123,383,451 |
RGD:1624291 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:1624291 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
IEA |
7 |
57,621,756 |
57,625,792 |
RGD:1600115 |
ENSEMBL |
complement activation, classical pathway
|
| G |
C1qa |
complement component 1, q subcomponent, A chain |
|
|
ISO |
5 |
155,662,333 |
155,665,180 |
RGD:1624291 |
RGD |
| G |
C1qa |
complement component 1, q subcomponent, A chain |
|
|
IEA |
5 |
155,662,333 |
155,665,180 |
RGD:1600115 |
ENSEMBL |
| G |
C1qb |
complement component 1, q subcomponent, B chain |
|
|
IEA |
5 |
155,647,524 |
155,653,074 |
RGD:1600115 |
UniProtKB |
| G |
C1qbp |
complement component 1, q subcomponent binding protein |
|
|
IEA |
10 |
57,881,783 |
57,886,434 |
RGD:1600115 |
UniProtKB |
| G |
C1qc |
complement component 1, q subcomponent, C chain |
|
|
IEA |
5 |
155,656,104 |
155,659,430 |
RGD:1600115 |
UniProtKB |
| G |
C1rl |
complement component 1, r subcomponent-like |
|
|
IEA |
4 |
160,694,113 |
160,708,614 |
RGD:1600115 |
UniProtKB |
| G |
C1s |
complement component 1, s subcomponent |
|
|
IEA |
4 |
160,736,133 |
160,748,133 |
RGD:1600115 |
UniProtKB |
| G |
C3 |
complement component 3 |
|
|
TAS |
|
|
|
RGD:1600605 |
RGD |
| G |
C4a |
complement component 4A (Rodgers blood group) |
|
|
NAS |
20 |
4,106,123 |
4,145,904 |
RGD:1600115 |
UniProtKB |
| G |
C4bpa |
complement component 4 binding protein, alpha |
|
|
IEA |
13 |
43,552,947 |
43,588,565 |
RGD:1600115 |
UniProtKB |
| G |
C4bpb |
complement component 4 binding protein, beta |
|
|
IEA |
13 |
43,598,158 |
43,608,875 |
RGD:1600115 |
UniProtKB |
| G |
C5 |
complement component 5 |
|
|
IEA |
3 |
14,011,115 |
14,102,744 |
RGD:1600115 |
UniProtKB |
| G |
C6 |
complement component 6 |
|
|
TAS |
2 |
53,691,290 |
53,764,539 |
RGD:704414 |
RGD |
| G |
C8b |
complement component 8, beta polypeptide |
|
|
IEA |
5 |
125,728,606 |
125,766,093 |
RGD:1600115 |
UniProtKB |
| G |
C9 |
complement component 9 |
|
|
TAS |
2 |
55,743,084 |
55,791,148 |
RGD:704414 |
RGD |
| G |
Cfi |
complement factor I |
|
|
IEA |
2 |
227,281,621 |
227,325,109 |
RGD:1600115 |
UniProtKB |
| G |
Cr1l |
complement component (3b/4b) receptor 1-like |
|
|
IEA |
13 |
111,010,296 |
111,057,427 |
RGD:1600115 |
UniProtKB |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
|
IMP |
13 |
88,702,243 |
88,703,153 |
RGD:1580273 |
RGD |
| G |
Mbl1 |
mannose-binding lectin (protein A) 1 |
|
|
IEA |
16 |
17,591,820 |
17,597,859 |
RGD:1600115 |
UniProtKB |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
|
IEA |
1 |
233,978,931 |
233,983,824 |
RGD:1600115 |
UniProtKB |
| G |
Serping1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
|
|
IEA |
3 |
67,968,808 |
67,978,102 |
RGD:1600115 |
UniProtKB |
cytotoxic T cell degranulation
|
| G |
Rab27a |
RAB27A, member RAS oncogene family |
|
|
ISO |
8 |
77,798,830 |
77,861,090 |
RGD:1624291 |
RGD |
| G |
Rab27a |
RAB27A, member RAS oncogene family |
|
|
IEA |
8 |
77,798,830 |
77,861,090 |
RGD:1600115 |
ENSEMBL |
dendritic cell cytokine production
|
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:1624291 |
RGD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
IEA |
14 |
34,906,043 |
34,984,819 |
RGD:1600115 |
ENSEMBL |
eosinophil degranulation
|
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
|
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:1624291 |
RGD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
|
ISS |
10 |
71,744,559 |
71,746,109 |
RGD:1600115 |
UniProtKB |
| G |
Vamp7 |
vesicle-associated membrane protein 7 |
|
|
IDA |
12 |
17,248,700 |
17,278,193 |
|
UniProtKB |
follicular B cell differentiation
|
| G |
Plcg2 |
phospholipase C, gamma 2 |
|
|
ISO |
19 |
47,875,572 |
47,947,573 |
RGD:1624291 |
RGD |
germinal center B cell differentiation
|
| G |
Ada |
adenosine deaminase |
|
|
ISO |
3 |
154,636,530 |
154,660,637 |
RGD:1624291 |
RGD |
| G |
Ada |
adenosine deaminase |
|
|
IEA |
3 |
154,636,530 |
154,660,637 |
RGD:1600115 |
ENSEMBL |
granuloma formation
|
| G |
Unc13d |
unc-13 homolog D (C. elegans) |
|
|
ISO |
10 |
106,170,475 |
106,185,215 |
RGD:1624291 |
RGD |
| G |
Unc13d |
unc-13 homolog D (C. elegans) |
|
|
IEA |
10 |
106,170,475 |
106,185,215 |
RGD:1600115 |
ENSEMBL |
histamine secretion by mast cell
|
| G |
Adora3 |
adenosine A3 receptor |
|
|
ISO |
2 |
201,157,782 |
201,161,425 |
RGD:1624291 |
RGD |
| G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
|
|
IMP |
X |
121,998,935 |
122,030,289 |
RGD:1600535 |
RGD |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
IMP |
5 |
16,933,111 |
17,054,564 |
RGD:1578516 |
RGD |
| G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
|
IMP |
7 |
72,283,825 |
72,306,126 |
RGD:1625716 |
RGD |
humoral immune response mediated by circulating immunoglobulin
|
| G |
Bcl3 |
B-cell CLL/lymphoma 3 |
|
|
ISO |
1 |
79,122,801 |
79,137,035 |
RGD:1624291 |
RGD |
| G |
Bcl3 |
B-cell CLL/lymphoma 3 |
|
|
IEA |
1 |
79,122,801 |
79,137,035 |
RGD:1600115 |
ENSEMBL |
| G |
Exo1 |
exonuclease 1 |
|
|
ISO |
13 |
91,619,024 |
91,644,366 |
RGD:1624291 |
RGD |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
|
ISO |
20 |
4,730,559 |
4,736,201 |
RGD:1624291 |
RGD |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
|
ISO |
20 |
4,671,489 |
4,681,058 |
RGD:1624291 |
RGD |
| G |
Zp3 |
zona pellucida glycoprotein 3 (sperm receptor) |
|
|
ISO |
12 |
21,805,746 |
21,812,711 |
RGD:1624291 |
RGD |
| G |
Zp3 |
zona pellucida glycoprotein 3 (sperm receptor) |
|
|
IEA |
12 |
21,805,746 |
21,812,711 |
RGD:1600115 |
ENSEMBL |
| G |
Zp3 |
zona pellucida glycoprotein 3 (sperm receptor) |
|
|
ISS |
12 |
21,805,746 |
21,812,711 |
RGD:1600115 |
UniProtKB |
immunoglobulin mediated immune response
|
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
|
ISO |
2 |
244,116,880 |
244,126,393 |
RGD:1624291 |
RGD |
| G |
C4b |
complement component 4B (Chido blood group) |
|
|
ISO |
20 |
4,300,687 |
4,315,882 |
RGD:1624291 |
RGD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
|
ISO |
18 |
56,756,511 |
56,765,711 |
RGD:1624291 |
RGD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
|
IEA |
18 |
56,756,511 |
56,765,711 |
RGD:1600115 |
ENSEMBL |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
IEA |
13 |
87,119,464 |
87,123,902 |
RGD:1600115 |
ENSEMBL |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
ISO |
13 |
86,809,011 |
86,823,599 |
RGD:1624291 |
RGD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
ISO |
13 |
86,809,011 |
86,823,599 |
RGD:1624291 |
RGD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
IEA |
13 |
86,809,011 |
86,823,599 |
RGD:1600115 |
ENSEMBL |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
|
|
ISO |
9 |
86,576,742 |
86,682,240 |
RGD:1624291 |
RGD |
| G |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
|
|
IEA |
9 |
86,576,742 |
86,682,240 |
RGD:1600115 |
ENSEMBL |
| G |
Irf7 |
interferon regulatory factor 7 |
|
|
ISO |
1 |
201,456,689 |
201,459,756 |
RGD:1624291 |
RGD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
|
IEA |
1 |
201,456,689 |
201,459,756 |
RGD:1600115 |
ENSEMBL |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
|
ISO |
8 |
124,299,729 |
124,303,798 |
RGD:1624291 |
RGD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
|
IEA |
8 |
124,299,729 |
124,303,798 |
RGD:1600115 |
ENSEMBL |
| G |
Prkcd |
protein kinase C, delta |
|
|
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:1624291 |
RGD |
| G |
Prkcd |
protein kinase C, delta |
|
|
IEA |
16 |
5,954,218 |
5,975,743 |
RGD:1600115 |
ENSEMBL |
| G |
RT1-DMa |
RT1 class II, locus DMa |
|
|
ISO |
20 |
4,843,458 |
4,846,861 |
RGD:1624291 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
IEP |
5 |
83,564,100 |
83,577,735 |
RGD:2312508 |
RGD |
| G |
Tnfsf13 |
tumor necrosis factor (ligand) superfamily, member 13 |
|
|
ISO |
10 |
56,499,945 |
56,502,928 |
RGD:1624291 |
RGD |
immunoglobulin production in mucosal tissue
|
| G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
|
|
ISO |
8 |
74,470,610 |
74,474,086 |
RGD:1624291 |
RGD |
| G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
|
|
IEA |
8 |
74,470,610 |
74,474,086 |
RGD:1600115 |
ENSEMBL |
| G |
Tnfsf13 |
tumor necrosis factor (ligand) superfamily, member 13 |
|
|
ISO |
10 |
56,499,945 |
56,502,928 |
RGD:1624291 |
RGD |
immunoglobulin production involved in immunoglobulin mediated immune response
|
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
ISO |
19 |
19,662,337 |
19,697,341 |
RGD:1624291 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
IEA |
19 |
19,662,337 |
19,697,341 |
RGD:1600115 |
ENSEMBL |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
|
ISO |
20 |
4,730,559 |
4,736,201 |
RGD:1624291 |
RGD |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
|
ISO |
20 |
4,671,489 |
4,681,058 |
RGD:1624291 |
RGD |
immunoglobulin secretion involved in immune response
|
| G |
Pou2f2 |
POU class 2 homeobox 2 |
|
|
ISO |
1 |
80,405,061 |
80,442,677 |
RGD:1624291 |
RGD |
immunoglobulin V(D)J recombination
|
| G |
Foxp1 |
forkhead box P1 |
|
|
ISO |
4 |
133,773,373 |
134,007,018 |
RGD:1624291 |
RGD |
| G |
Foxp1 |
forkhead box P1 |
|
|
IBA |
4 |
133,773,373 |
134,007,018 |
RGD:1600115 |
RefGenome |
| G |
Lig4 |
ligase IV, DNA, ATP-dependent |
|
|
ISO |
16 |
84,881,880 |
84,888,448 |
RGD:1624291 |
RGD |
| G |
Lig4 |
ligase IV, DNA, ATP-dependent |
|
|
IEA |
16 |
84,881,880 |
84,888,448 |
RGD:1600115 |
ENSEMBL |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
|
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:1624291 |
RGD |
| G |
Tcf3 |
transcription factor 3 |
|
|
ISO |
7 |
10,791,311 |
10,813,613 |
RGD:1624291 |
RGD |
| G |
Tcf3 |
transcription factor 3 |
|
|
ISO |
7 |
10,791,311 |
10,813,613 |
RGD:1624291 |
RGD |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
|
ISO |
2 |
19,904,490 |
20,158,358 |
RGD:1624291 |
RGD |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
|
IEA |
2 |
19,904,490 |
20,158,358 |
RGD:1600115 |
ENSEMBL |
interleukin-4-dependent isotype switching to IgE isotypes
|
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
ISO |
13 |
77,026,337 |
77,050,223 |
RGD:1624291 |
RGD |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
IEA |
13 |
77,026,337 |
77,050,223 |
RGD:1600115 |
ENSEMBL |
isotype switching
|
| G |
aicda |
activation-induced cytidine deaminase |
|
|
ISO |
4 |
159,006,328 |
159,017,501 |
RGD:1624291 |
RGD |
| G |
aicda |
activation-induced cytidine deaminase |
|
|
IEA |
4 |
159,006,328 |
159,017,501 |
RGD:1600115 |
ENSEMBL |
| G |
Batf |
basic leucine zipper transcription factor, ATF-like |
|
|
ISS |
6 |
109,793,076 |
109,817,614 |
RGD:1600115 |
UniProtKB |
| G |
Batf |
basic leucine zipper transcription factor, ATF-like |
|
|
ISO |
6 |
109,793,076 |
109,817,614 |
RGD:1624291 |
RGD |
| G |
Batf |
basic leucine zipper transcription factor, ATF-like |
|
|
ISO |
6 |
109,793,076 |
109,817,614 |
RGD:1624291 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
ISO |
X |
141,925,019 |
141,937,183 |
RGD:1624291 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
IEA |
X |
141,925,019 |
141,937,183 |
RGD:1600115 |
ENSEMBL |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
|
ISO |
1 |
78,711,249 |
78,722,474 |
RGD:1624291 |
RGD |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
|
IEA |
1 |
78,711,249 |
78,722,474 |
RGD:1600115 |
ENSEMBL |
| G |
Exo1 |
exonuclease 1 |
|
|
ISO |
13 |
91,619,024 |
91,644,366 |
RGD:1624291 |
RGD |
| G |
Exosc3 |
exosome component 3 |
|
|
ISO |
5 |
61,880,622 |
61,883,825 |
RGD:1624291 |
RGD |
| G |
Exosc6 |
exosome component 6 |
|
|
ISO |
19 |
40,975,037 |
40,976,299 |
RGD:1624291 |
RGD |
| G |
Lig4 |
ligase IV, DNA, ATP-dependent |
|
|
ISO |
16 |
84,881,880 |
84,888,448 |
RGD:1624291 |
RGD |
| G |
Lig4 |
ligase IV, DNA, ATP-dependent |
|
|
IEA |
16 |
84,881,880 |
84,888,448 |
RGD:1600115 |
ENSEMBL |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:1624291 |
RGD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
IEA |
8 |
115,616,396 |
115,653,471 |
RGD:1600115 |
ENSEMBL |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
IEA |
6 |
11,199,906 |
11,258,350 |
RGD:1600115 |
ENSEMBL |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
IBA |
6 |
11,199,906 |
11,258,350 |
RGD:1600115 |
RefGenome |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
|
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:1624291 |
RGD |
| G |
Nbn |
nibrin |
|
|
ISO |
5 |
30,541,610 |
30,576,168 |
RGD:1624291 |
RGD |
| G |
Nbn |
nibrin |
|
|
IEA |
5 |
30,541,610 |
30,576,168 |
RGD:1600115 |
ENSEMBL |
| G |
Nbn |
nibrin |
|
|
ISS |
5 |
30,541,610 |
30,576,168 |
RGD:1600115 |
UniProtKB |
| G |
Rnf168 |
ring finger protein 168, E3 ubiquitin protein ligase |
|
|
ISS |
11 |
70,304,917 |
70,328,010 |
RGD:1600115 |
UniProtKB |
| G |
Rnf168 |
ring finger protein 168, E3 ubiquitin protein ligase |
|
|
ISO |
11 |
70,304,917 |
70,328,010 |
RGD:1624291 |
RGD |
| G |
Rnf8 |
ring finger protein 8, E3 ubiquitin protein ligase |
|
|
ISO |
20 |
7,929,802 |
7,954,697 |
RGD:1624291 |
RGD |
| G |
Rnf8 |
ring finger protein 8, E3 ubiquitin protein ligase |
|
|
ISS |
20 |
7,929,802 |
7,954,697 |
RGD:1600115 |
UniProtKB |
| G |
Swap70 |
SWAP switching B-cell complex 70 |
|
|
ISO |
1 |
167,888,783 |
167,949,621 |
RGD:1624291 |
RGD |
| G |
Swap70 |
SWAP switching B-cell complex 70 |
|
|
IEA |
1 |
167,888,783 |
167,949,621 |
RGD:1600115 |
ENSEMBL |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
|
ISO |
2 |
19,904,490 |
20,158,358 |
RGD:1624291 |
RGD |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
|
IEA |
2 |
19,904,490 |
20,158,358 |
RGD:1600115 |
ENSEMBL |
isotype switching to IgG isotypes
|
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
|
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:1624291 |
RGD |
leukocyte activation involved in immune response
|
| G |
Clec7a |
C-type lectin domain family 7, member A |
|
|
ISO |
4 |
166,723,515 |
166,734,681 |
RGD:1624291 |
RGD |
| G |
Sh2d1b |
SH2 domain containing 1B |
|
|
ISO |
13 |
86,096,465 |
86,126,881 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISS |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
UniProtKB |
leukocyte homeostasis
|
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
|
ISO |
20 |
5,255,954 |
5,264,593 |
RGD:1624291 |
RGD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
|
ISO |
20 |
5,255,954 |
5,264,593 |
RGD:1624291 |
RGD |
| G |
Bax |
Bcl2-associated X protein |
|
|
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:1624291 |
RGD |
| G |
Bax |
Bcl2-associated X protein |
|
|
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:1624291 |
RGD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
|
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:1624291 |
RGD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
|
IEA |
14 |
18,825,357 |
18,826,269 |
RGD:1600115 |
ENSEMBL |
| G |
Flt3 |
fms-related tyrosine kinase 3 |
|
|
IMP |
12 |
8,193,629 |
8,268,682 |
RGD:2290270 |
UniProtKB |
| G |
Flt3 |
fms-related tyrosine kinase 3 |
|
|
ISO |
12 |
8,193,629 |
8,268,682 |
RGD:1624291 |
RGD |
| G |
Flt3 |
fms-related tyrosine kinase 3 |
|
|
ISO |
12 |
8,193,629 |
8,268,682 |
RGD:2290270 |
RGD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
|
ISO |
1 |
209,114,987 |
209,120,837 |
RGD:1624291 |
RGD |
| G |
Nkx2-3 |
NK2 homeobox 3 |
|
|
ISO |
1 |
247,221,087 |
247,224,040 |
RGD:1624291 |
RGD |
| G |
Nkx2-3 |
NK2 homeobox 3 |
|
|
IEA |
1 |
247,221,087 |
247,224,040 |
RGD:1600115 |
ENSEMBL |
leukocyte mediated cytotoxicity
|
| G |
Ncf1 |
neutrophil cytosolic factor 1 |
|
|
ISO |
12 |
23,578,097 |
23,587,292 |
RGD:1624291 |
RGD |
| G |
Stxbp2 |
syntaxin binding protein 2 |
|
|
ISO |
12 |
2,511,793 |
2,522,818 |
RGD:1624291 |
RGD |
| G |
Stxbp2 |
syntaxin binding protein 2 |
|
|
IEA |
12 |
2,511,793 |
2,522,818 |
RGD:1600115 |
ENSEMBL |
leukocyte mediated immunity
|
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
|
ISO |
3 |
6,052,706 |
6,069,826 |
RGD:1624291 |
RGD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
|
IEA |
3 |
6,052,706 |
6,069,826 |
RGD:1600115 |
ENSEMBL |
leukocyte migration involved in immune response
|
| G |
Fut7 |
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
|
|
ISO |
3 |
3,590,174 |
3,593,046 |
RGD:1624291 |
RGD |
| G |
Fut7 |
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
|
|
IEA |
3 |
3,590,174 |
3,593,046 |
RGD:1600115 |
ENSEMBL |
lymphocyte homeostasis
|
| G |
Ahr |
aryl hydrocarbon receptor |
|
|
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:1624291 |
RGD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
|
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:1624291 |
RGD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
|
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:1624291 |
RGD |
| G |
Foxn1 |
forkhead box N1 |
|
|
ISO |
10 |
64,243,323 |
64,256,847 |
RGD:1624291 |
RGD |
| G |
Foxn1 |
forkhead box N1 |
|
|
IEA |
10 |
64,243,323 |
64,256,847 |
RGD:1600115 |
ENSEMBL |
| G |
Skil |
SKI-like oncogene |
|
|
ISO |
2 |
116,669,375 |
116,691,472 |
RGD:1624291 |
RGD |
| G |
Skil |
SKI-like oncogene |
|
|
IEA |
2 |
116,669,375 |
116,691,472 |
RGD:1600115 |
ENSEMBL |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
|
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:1624291 |
RGD |
| G |
Spta1 |
spectrin, alpha, erythrocytic 1 (elliptocytosis 2) |
|
|
ISO |
13 |
89,951,924 |
90,028,592 |
RGD:1624291 |
RGD |
macrophage activation involved in immune response
|
| G |
Lbp |
lipopolysaccharide binding protein |
|
|
ISO |
3 |
149,016,605 |
149,043,530 |
RGD:1624291 |
RGD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
|
IEA |
3 |
149,016,605 |
149,043,530 |
RGD:1600115 |
ENSEMBL |
| G |
Prkce |
protein kinase C, epsilon |
|
|
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:1624291 |
RGD |
| G |
Prkce |
protein kinase C, epsilon |
|
|
IEA |
6 |
9,631,234 |
10,097,311 |
RGD:1600115 |
ENSEMBL |
| G |
Sbno2 |
strawberry notch homolog 2 (Drosophila) |
|
|
ISO |
7 |
11,117,835 |
11,161,863 |
RGD:1624291 |
RGD |
| G |
Sbno2 |
strawberry notch homolog 2 (Drosophila) |
|
|
ISO |
7 |
11,117,835 |
11,161,863 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
IEA |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
ENSEMBL |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISS |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
UniProtKB |
| G |
Tyrobp |
Tyro protein tyrosine kinase binding protein |
|
|
ISO |
1 |
85,365,371 |
85,369,224 |
RGD:1624291 |
RGD |
| G |
Tyrobp |
Tyro protein tyrosine kinase binding protein |
|
|
IEA |
1 |
85,365,371 |
85,369,224 |
RGD:1600115 |
ENSEMBL |
marginal zone B cell differentiation
|
| G |
Bcl3 |
B-cell CLL/lymphoma 3 |
|
|
ISO |
1 |
79,122,801 |
79,137,035 |
RGD:1624291 |
RGD |
| G |
Bcl3 |
B-cell CLL/lymphoma 3 |
|
|
IEA |
1 |
79,122,801 |
79,137,035 |
RGD:1600115 |
ENSEMBL |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
ISS |
15 |
45,589,222 |
45,717,866 |
RGD:1600115 |
UniProtKB |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
ISO |
15 |
45,589,222 |
45,717,866 |
RGD:1624291 |
RGD |
mast cell degranulation
|
| G |
Cplx2 |
complexin 2 |
|
|
IEA |
17 |
16,314,592 |
16,322,938 |
RGD:1600115 |
UniProtKB |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:1624291 |
RGD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
IEA |
14 |
34,906,043 |
34,984,819 |
RGD:1600115 |
ENSEMBL |
| G |
Lat |
linker for activation of T cells |
|
|
IEA |
1 |
185,450,155 |
185,455,180 |
RGD:1600115 |
UniProtKB |
| G |
Lat2 |
linker for activation of T cells family, member 2 |
|
|
IEA |
12 |
23,174,554 |
23,180,908 |
RGD:1600115 |
UniProtKB |
| G |
Milr1 |
mast cell immunoglobulin-like receptor 1 |
|
|
ISO |
10 |
96,110,944 |
96,111,829 |
RGD:1624291 |
RGD |
| G |
Milr1 |
mast cell immunoglobulin-like receptor 1 |
|
|
ISS |
10 |
96,110,944 |
96,111,829 |
RGD:1600115 |
UniProtKB |
| G |
Rasgrp1 |
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
|
|
ISO |
3 |
103,371,879 |
103,433,010 |
RGD:1624291 |
RGD |
| G |
Tac4 |
tachykinin 4 (hemokinin) |
|
|
IEA |
10 |
83,946,235 |
83,954,475 |
RGD:1600115 |
UniProtKB |
mast cell mediated immunity
|
| G |
Serpinb9 |
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
|
|
ISO |
17 |
37,780,179 |
37,791,625 |
RGD:1624291 |
RGD |
mature B cell differentiation involved in immune response
|
| G |
Gpr183 |
G protein-coupled receptor 183 |
|
|
ISO |
15 |
107,056,367 |
107,067,887 |
RGD:1624291 |
RGD |
| G |
Gpr183 |
G protein-coupled receptor 183 |
|
|
IEA |
15 |
107,056,367 |
107,067,887 |
RGD:1600115 |
ENSEMBL |
microglial cell activation involved in immune response
|
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
|
ISO |
8 |
125,033,630 |
125,047,335 |
RGD:1624291 |
RGD |
| G |
Cx3cr1 |
chemokine (C-X3-C motif) receptor 1 |
|
|
IEA |
8 |
125,033,630 |
125,047,335 |
RGD:1600115 |
ENSEMBL |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
IDA |
19 |
19,662,337 |
19,697,341 |
RGD:1643119 |
RGD |
| G |
Tlr1 |
toll-like receptor 1 |
|
|
IDA |
|
|
|
RGD:1643119 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
IDA |
2 |
175,607,990 |
175,613,992 |
RGD:1643119 |
RGD |
| G |
Tlr3 |
toll-like receptor 3 |
|
|
IDA |
16 |
50,112,910 |
50,126,371 |
RGD:1643119 |
RGD |
| G |
Tlr3 |
toll-like receptor 3 |
|
|
IMP |
16 |
50,112,910 |
50,126,371 |
RGD:5128688 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
IDA |
5 |
83,564,100 |
83,577,735 |
RGD:1643119 |
RGD |
| G |
Tlr6 |
toll-like receptor 6 |
|
|
IDA |
14 |
46,089,365 |
46,100,687 |
RGD:1643119 |
RGD |
| G |
Tlr7 |
toll-like receptor 7 |
|
|
IDA |
X |
47,330,737 |
47,356,841 |
RGD:1643119 |
RGD |
| G |
Tlr8 |
toll-like receptor 8 |
|
|
IDA |
|
|
|
RGD:1643119 |
RGD |
| G |
Tlr9 |
toll-like receptor 9 |
|
|
IDA |
|
|
|
RGD:1643119 |
RGD |
myeloid dendritic cell activation involved in immune response
|
| G |
Dock2 |
dedicator of cytokinesis 2 |
|
|
ISO |
10 |
19,207,499 |
19,660,353 |
RGD:1624291 |
RGD |
| G |
Pycard |
PYD and CARD domain containing |
|
|
ISO |
1 |
187,276,089 |
187,277,122 |
RGD:1624291 |
RGD |
| G |
Pycard |
PYD and CARD domain containing |
|
|
IEA |
1 |
187,276,089 |
187,277,122 |
RGD:1600115 |
ENSEMBL |
myeloid dendritic cell cytokine production
|
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
NOT |
ISO |
18 |
25,404,123 |
25,625,785 |
RGD:1624291 |
RGD |
natural killer cell activation involved in immune response
|
| G |
Ifna16l1 |
interferon, alpha 16-like 1 |
|
|
ISO |
5 |
108,070,121 |
108,070,696 |
RGD:1624291 |
RGD |
| G |
Il12b |
interleukin 12B |
|
|
IMP |
10 |
29,558,955 |
29,568,331 |
RGD:1600048 |
RGD |
natural killer cell degranulation
|
| G |
Rab27a |
RAB27A, member RAS oncogene family |
|
|
ISO |
8 |
77,798,830 |
77,861,090 |
RGD:1624291 |
RGD |
| G |
Rab27a |
RAB27A, member RAS oncogene family |
|
|
IEA |
8 |
77,798,830 |
77,861,090 |
RGD:1600115 |
ENSEMBL |
| G |
Unc13d |
unc-13 homolog D (C. elegans) |
|
|
ISO |
10 |
106,170,475 |
106,185,215 |
RGD:1624291 |
RGD |
| G |
Unc13d |
unc-13 homolog D (C. elegans) |
|
|
IEA |
10 |
106,170,475 |
106,185,215 |
RGD:1600115 |
ENSEMBL |
natural killer cell mediated cytotoxicity
|
| G |
Cebpg |
CCAAT/enhancer binding protein (C/EBP), gamma |
|
|
ISO |
1 |
87,552,695 |
87,559,447 |
RGD:1624291 |
RGD |
| G |
Cebpg |
CCAAT/enhancer binding protein (C/EBP), gamma |
|
|
ISS |
1 |
87,552,695 |
87,559,447 |
RGD:1600115 |
UniProtKB |
| G |
Lyst |
lysosomal trafficking regulator |
|
|
ISO |
17 |
66,569,478 |
66,735,402 |
RGD:1624291 |
RGD |
| G |
Lyst |
lysosomal trafficking regulator |
|
|
ISO |
17 |
66,569,478 |
66,735,402 |
RGD:1624291 |
RGD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
|
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:1624291 |
RGD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
|
IEA |
5 |
136,975,780 |
136,991,630 |
RGD:1600115 |
ENSEMBL |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
|
ISO |
4 |
160,843,699 |
160,868,856 |
RGD:1624291 |
RGD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
|
IEA |
4 |
160,843,699 |
160,868,856 |
RGD:1600115 |
ENSEMBL |
negative regulation of activation of membrane attack complex
|
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
|
IDA |
3 |
89,243,600 |
89,245,129 |
RGD:1600482 |
RGD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
|
ISO |
3 |
89,243,600 |
89,245,129 |
RGD:1624291 |
RGD |
negative regulation of activation-induced cell death of T cells
|
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
|
ISO |
1 |
261,370,264 |
261,431,434 |
RGD:1624291 |
RGD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
|
IEA |
1 |
261,370,264 |
261,431,434 |
RGD:1600115 |
ENSEMBL |
negative regulation of complement activation
|
| G |
Cd46 |
CD46 molecule, complement regulatory protein |
|
|
IDA |
13 |
110,972,812 |
111,003,407 |
RGD:2293559 |
RGD |
| G |
Cd55 |
Cd55 molecule |
|
|
IDA |
13 |
43,322,246 |
43,348,334 |
RGD:2326180 |
RGD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
|
ISO |
3 |
89,243,600 |
89,245,129 |
RGD:1624291 |
RGD |
| G |
Cr1l |
complement component (3b/4b) receptor 1-like |
|
|
IMP |
13 |
111,010,296 |
111,057,427 |
RGD:625470 |
RGD |
| G |
Cr1l |
complement component (3b/4b) receptor 1-like |
|
|
ISO |
13 |
111,010,296 |
111,057,427 |
RGD:1624291 |
RGD |
| G |
Masp1 |
mannan-binding lectin serine peptidase 1 |
|
|
ISO |
11 |
79,532,504 |
79,602,755 |
RGD:1624291 |
RGD |
| G |
Masp1 |
mannan-binding lectin serine peptidase 1 |
|
|
IEA |
11 |
79,532,504 |
79,602,755 |
RGD:1600115 |
ENSEMBL |
negative regulation of complement activation, lectin pathway
|
| G |
A2m |
alpha-2-macroglobulin |
|
|
ISO |
4 |
158,103,711 |
158,153,423 |
RGD:1624291 |
RGD |
| G |
Serping1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
|
|
ISO |
3 |
67,968,808 |
67,978,102 |
RGD:1624291 |
RGD |
| G |
Serping1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
|
|
ISS |
3 |
67,968,808 |
67,978,102 |
RGD:1600115 |
UniProtKB |
negative regulation of defense response to virus
|
| G |
C1qbp |
complement component 1, q subcomponent binding protein |
|
|
ISS |
10 |
57,881,783 |
57,886,434 |
RGD:1600115 |
UniProtKB |
| G |
C1qbp |
complement component 1, q subcomponent binding protein |
|
|
ISO |
10 |
57,881,783 |
57,886,434 |
RGD:1624291 |
RGD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
|
IMP |
17 |
78,050,491 |
78,097,802 |
RGD:2325989 |
RGD |
| G |
Itch |
itchy E3 ubiquitin protein ligase |
|
|
ISO |
3 |
145,644,315 |
145,707,190 |
RGD:1624291 |
RGD |
| G |
Itch |
itchy E3 ubiquitin protein ligase |
|
|
ISO |
3 |
145,644,315 |
145,707,190 |
RGD:1624291 |
RGD |
| G |
Itch |
itchy E3 ubiquitin protein ligase |
|
|
IEA |
3 |
145,644,315 |
145,707,190 |
RGD:1600115 |
ENSEMBL |
| G |
Itch |
itchy E3 ubiquitin protein ligase |
|
|
IEA |
3 |
145,644,315 |
145,707,190 |
RGD:1600115 |
ENSEMBL |
| G |
Pcbp2 |
poly(rC) binding protein 2 |
|
|
ISO |
7 |
141,232,766 |
141,253,910 |
RGD:1624291 |
RGD |
| G |
Pcbp2 |
poly(rC) binding protein 2 |
|
|
IEA |
7 |
141,232,766 |
141,253,910 |
RGD:1600115 |
ENSEMBL |
negative regulation of defense response to virus by host
|
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
|
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:1624291 |
RGD |
| G |
Irf3 |
interferon regulatory factor 3 |
|
|
ISO |
1 |
95,470,284 |
95,475,078 |
RGD:1624291 |
RGD |
| G |
Irf3 |
interferon regulatory factor 3 |
|
|
IEA |
1 |
95,470,284 |
95,475,078 |
RGD:1600115 |
ENSEMBL |
| G |
Micb |
MHC class I polypeptide-related sequence B |
|
|
ISO |
1 |
78,199,668 |
78,216,687 |
RGD:1624291 |
RGD |
| G |
Micb |
MHC class I polypeptide-related sequence B |
|
|
ISO |
1 |
78,199,668 |
78,216,687 |
RGD:1624291 |
RGD |
| G |
Tarbp2 |
TAR (HIV-1) RNA binding protein 2 |
|
|
ISO |
7 |
141,272,043 |
141,273,188 |
RGD:1624291 |
RGD |
| G |
Tarbp2 |
TAR (HIV-1) RNA binding protein 2 |
|
|
ISS |
7 |
141,272,043 |
141,273,188 |
RGD:1600115 |
UniProtKB |
negative regulation of dendritic cell cytokine production
|
| G |
Jak3 |
Janus kinase 3 |
|
|
ISO |
16 |
18,878,139 |
18,889,441 |
RGD:1624291 |
RGD |
| G |
Jak3 |
Janus kinase 3 |
|
|
ISS |
16 |
18,878,139 |
18,889,441 |
RGD:1600115 |
BHF-UCL |
negative regulation of eosinophil degranulation
|
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
|
ISS |
8 |
128,892,784 |
128,893,905 |
RGD:1600115 |
BHF-UCL |
negative regulation of humoral immune response mediated by circulating immunoglobulin
|
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
ISO |
13 |
86,809,011 |
86,823,599 |
RGD:1624291 |
RGD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
IEA |
13 |
86,809,011 |
86,823,599 |
RGD:1600115 |
ENSEMBL |
| G |
Foxj1 |
forkhead box J1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Foxj1 |
forkhead box J1 |
|
|
IBA |
|
|
|
RGD:1600115 |
RefGenome |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
|
ISO |
4 |
160,843,699 |
160,868,856 |
RGD:1624291 |
RGD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
|
IEA |
4 |
160,843,699 |
160,868,856 |
RGD:1600115 |
ENSEMBL |
negative regulation of immunoglobulin production
|
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
ISO |
13 |
86,809,011 |
86,823,599 |
RGD:1624291 |
RGD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
IEA |
13 |
86,809,011 |
86,823,599 |
RGD:1600115 |
ENSEMBL |
negative regulation of isotype switching to IgE isotypes
|
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
|
ISO |
11 |
79,006,123 |
79,030,555 |
RGD:1624291 |
RGD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
|
IEA |
11 |
79,006,123 |
79,030,555 |
RGD:1600115 |
ENSEMBL |
| G |
Foxp3 |
forkhead box P3 |
|
|
ISO |
X |
26,950,006 |
26,965,329 |
RGD:1624291 |
RGD |
| G |
Foxp3 |
forkhead box P3 |
|
|
IBA |
X |
26,950,006 |
26,965,329 |
RGD:1600115 |
RefGenome |
| G |
Ndfip1 |
Nedd4 family interacting protein 1 |
|
|
ISO |
18 |
31,351,538 |
31,401,736 |
RGD:1624291 |
RGD |
| G |
Ndfip1 |
Nedd4 family interacting protein 1 |
|
|
IEA |
18 |
31,351,538 |
31,401,736 |
RGD:1600115 |
ENSEMBL |
negative regulation of macrophage cytokine production
|
| G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
|
ISO |
7 |
59,408,198 |
59,467,821 |
RGD:1624291 |
RGD |
| G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
|
IEA |
7 |
59,408,198 |
59,467,821 |
RGD:1600115 |
ENSEMBL |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:1624291 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
IEA |
1 |
80,894,705 |
80,911,020 |
RGD:1600115 |
ENSEMBL |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
|
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:1624291 |
RGD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
|
IEA |
13 |
102,718,703 |
102,818,768 |
RGD:1600115 |
ENSEMBL |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
|
ISS |
13 |
102,718,703 |
102,818,768 |
RGD:1600115 |
UniProtKB |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
|
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:1624291 |
RGD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
|
IEA |
6 |
110,173,443 |
110,195,215 |
RGD:1600115 |
ENSEMBL |
negative regulation of mast cell activation involved in immune response
|
| G |
Fert2 |
fer (fms/fps related) protein kinase, testis specific 2 |
|
|
ISS |
9 |
102,645,929 |
102,861,698 |
RGD:1600115 |
UniProtKB |
negative regulation of mast cell apoptotic process
|
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
IEA |
13 |
87,119,464 |
87,123,902 |
RGD:1600115 |
ENSEMBL |
| G |
Il3 |
interleukin 3 |
|
|
ISO |
10 |
39,684,691 |
39,687,041 |
RGD:1624291 |
RGD |
| G |
Il3 |
interleukin 3 |
|
|
IEA |
10 |
39,684,691 |
39,687,041 |
RGD:1600115 |
ENSEMBL |
| G |
Kitlg |
KIT ligand |
|
|
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:1624291 |
RGD |
| G |
Kitlg |
KIT ligand |
|
|
IEA |
7 |
37,714,157 |
37,795,722 |
RGD:1600115 |
ENSEMBL |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
|
ISO |
10 |
89,795,404 |
89,819,732 |
RGD:1624291 |
RGD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
|
IEA |
10 |
89,795,404 |
89,819,732 |
RGD:1600115 |
ENSEMBL |
negative regulation of mast cell cytokine production
|
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
|
ISO |
11 |
79,006,123 |
79,030,555 |
RGD:1624291 |
RGD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
|
IEA |
11 |
79,006,123 |
79,030,555 |
RGD:1600115 |
ENSEMBL |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
IDA |
19 |
13,963,139 |
13,969,960 |
RGD:1601626 |
RGD |
negative regulation of mast cell degranulation
|
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
IDA |
19 |
13,963,139 |
13,969,960 |
RGD:1601626 |
RGD |
| G |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
|
|
ISO |
12 |
27,497,545 |
27,525,385 |
RGD:1624291 |
RGD |
| G |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
|
|
IEA |
12 |
27,497,545 |
27,525,385 |
RGD:1600115 |
ENSEMBL |
negative regulation of mature B cell apoptotic process
|
| G |
Ada |
adenosine deaminase |
|
|
ISO |
3 |
154,636,530 |
154,660,637 |
RGD:1624291 |
RGD |
| G |
Ada |
adenosine deaminase |
|
|
IEA |
3 |
154,636,530 |
154,660,637 |
RGD:1600115 |
ENSEMBL |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
|
ISO |
2 |
244,116,880 |
244,126,393 |
RGD:1624291 |
RGD |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
|
ISS |
2 |
244,116,880 |
244,126,393 |
RGD:1600115 |
UniProtKB |
| G |
Cd44 |
Cd44 molecule |
|
|
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:1624291 |
RGD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
|
ISO |
18 |
56,756,511 |
56,765,711 |
RGD:1624291 |
RGD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
|
ISS |
18 |
56,756,511 |
56,765,711 |
RGD:1600115 |
BHF-UCL |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISO |
20 |
13,191,986 |
13,192,851 |
RGD:1624291 |
RGD |
negative regulation of natural killer cell differentiation involved in immune response
|
| G |
LOC100910179 |
peptidoglycan recognition protein 4-like |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
LOC299567 |
similar to Peptidoglycan recognition protein-like |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
|
ISO |
1 |
78,235,474 |
78,240,665 |
RGD:1624291 |
RGD |
| G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
|
IEA |
1 |
78,235,474 |
78,240,665 |
RGD:1600115 |
ENSEMBL |
| G |
Pglyrp3 |
peptidoglycan recognition protein 3 |
|
|
ISO |
2 |
184,874,939 |
184,884,692 |
RGD:1624291 |
RGD |
| G |
Pglyrp4 |
peptidoglycan recognition protein 4 |
|
|
ISO |
2 |
183,015,945 |
183,038,181 |
RGD:1624291 |
RGD |
| G |
Pglyrp4 |
peptidoglycan recognition protein 4 |
|
|
IEA |
2 |
183,015,945 |
183,038,181 |
RGD:1600115 |
ENSEMBL |
negative regulation of natural killer cell mediated cytotoxicity
|
| G |
Arrb2 |
arrestin, beta 2 |
|
|
ISO |
10 |
57,244,071 |
57,284,166 |
RGD:1624291 |
RGD |
| G |
Arrb2 |
arrestin, beta 2 |
|
|
IEA |
10 |
57,244,071 |
57,284,166 |
RGD:1600115 |
ENSEMBL |
| G |
LOC687009 |
similar to EAT-2-related transducer |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
RT1-A1 |
RT1 class Ia, locus A1 |
|
|
IMP |
20 |
5,056,763 |
5,060,280 |
RGD:2313500 |
RGD |
| G |
Sh2d1b |
SH2 domain containing 1B |
|
|
ISO |
13 |
86,096,465 |
86,126,881 |
RGD:1624291 |
RGD |
| G |
Sh2d1b |
SH2 domain containing 1B |
|
|
IEA |
13 |
86,096,465 |
86,126,881 |
RGD:1600115 |
ENSEMBL |
| G |
Sh2d1b2 |
SH2 domain protein 1B2 |
|
|
ISO |
13 |
86,047,216 |
86,067,302 |
RGD:1624291 |
RGD |
| G |
Sh2d1b2 |
SH2 domain protein 1B2 |
|
|
IEA |
13 |
86,047,216 |
86,067,302 |
RGD:1600115 |
ENSEMBL |
negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target
|
| G |
Klre1 |
killer cell lectin-like receptor, family E, member 1 |
|
|
IDA |
4 |
166,857,685 |
166,864,221 |
RGD:1299590 |
RGD |
negative regulation of neutrophil degranulation
|
| G |
Abr |
active BCR-related |
|
|
ISO |
10 |
67,617,776 |
67,760,961 |
RGD:1624291 |
RGD |
| G |
Abr |
active BCR-related |
|
|
IEA |
10 |
67,617,776 |
67,760,961 |
RGD:1600115 |
ENSEMBL |
| G |
Bcr |
breakpoint cluster region |
|
|
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:1624291 |
RGD |
| G |
Bcr |
breakpoint cluster region |
|
|
IEA |
20 |
13,972,773 |
14,097,816 |
RGD:1600115 |
ENSEMBL |
negative regulation of plasmacytoid dendritic cell cytokine production
|
| G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
|
ISO |
16 |
18,698,545 |
18,701,768 |
RGD:1624291 |
RGD |
| G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
|
ISS |
16 |
18,698,545 |
18,701,768 |
RGD:1600115 |
UniProtKB |
negative regulation of respiratory burst involved in inflammatory response
|
| G |
Dusp10 |
dual specificity phosphatase 10 |
|
|
ISO |
13 |
100,022,421 |
100,059,539 |
RGD:1624291 |
RGD |
| G |
Dusp10 |
dual specificity phosphatase 10 |
|
|
IEA |
13 |
100,022,421 |
100,059,539 |
RGD:1600115 |
ENSEMBL |
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
| G |
Rps19 |
ribosomal protein S19 |
|
|
ISO |
1 |
80,176,649 |
80,182,351 |
RGD:1624291 |
RGD |
negative regulation of T cell cytokine production
|
| G |
Foxp3 |
forkhead box P3 |
|
|
IBA |
X |
26,950,006 |
26,965,329 |
RGD:1600115 |
RefGenome |
| G |
Foxp3 |
forkhead box P3 |
|
|
ISO |
X |
26,950,006 |
26,965,329 |
RGD:1624291 |
RGD |
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
ISO |
13 |
80,691,195 |
80,694,638 |
RGD:1624291 |
RGD |
negative regulation of T cell homeostatic proliferation
|
| G |
Cd24 |
CD24 molecule |
|
|
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:1624291 |
RGD |
| G |
Cd24 |
CD24 molecule |
|
|
IEA |
20 |
47,502,354 |
47,507,663 |
RGD:1600115 |
ENSEMBL |
negative regulation of T cell mediated cytotoxicity
|
| G |
Il7r |
interleukin 7 receptor |
|
|
ISO |
2 |
59,103,992 |
59,128,004 |
RGD:1624291 |
RGD |
| G |
Il7r |
interleukin 7 receptor |
|
|
IEA |
2 |
59,103,992 |
59,128,004 |
RGD:1600115 |
ENSEMBL |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isozyme |
|
|
ISO |
15 |
3,986,290 |
4,030,352 |
RGD:1624291 |
RGD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isozyme |
|
|
IEA |
15 |
3,986,290 |
4,030,352 |
RGD:1600115 |
ENSEMBL |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISS |
13 |
51,246,163 |
51,357,995 |
RGD:1600115 |
UniProtKB |
negative regulation of T cell mediated cytotoxicity directed against tumor cell target
|
| G |
Muc4 |
mucin 4, cell surface associated |
|
|
IDA |
11 |
69,830,276 |
69,858,366 |
RGD:2303754 |
RGD |
negative regulation of T cell mediated immunity
|
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
ISO |
19 |
19,662,337 |
19,697,341 |
RGD:1624291 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
IEA |
19 |
19,662,337 |
19,697,341 |
RGD:1600115 |
ENSEMBL |
negative regulation of T-helper 1 cell differentiation
|
| G |
Il4r |
interleukin 4 receptor |
|
|
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:1624291 |
RGD |
| G |
Il4r |
interleukin 4 receptor |
|
|
IEA |
1 |
184,612,903 |
184,637,863 |
RGD:1600115 |
ENSEMBL |
| G |
Jak3 |
Janus kinase 3 |
|
|
ISO |
16 |
18,878,139 |
18,889,441 |
RGD:1624291 |
RGD |
| G |
Jak3 |
Janus kinase 3 |
|
|
ISS |
16 |
18,878,139 |
18,889,441 |
RGD:1600115 |
BHF-UCL |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
ISO |
13 |
77,026,337 |
77,050,223 |
RGD:1624291 |
RGD |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
IEA |
13 |
77,026,337 |
77,050,223 |
RGD:1600115 |
ENSEMBL |
negative regulation of T-helper 17 cell differentiation
|
| G |
Il4 |
interleukin 4 |
|
|
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:1624291 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
IEA |
10 |
39,074,582 |
39,080,134 |
RGD:1600115 |
ENSEMBL |
negative regulation of T-helper 2 cell cytokine production
|
| G |
Ifnb1 |
interferon beta 1, fibroblast |
|
|
ISO |
5 |
107,837,628 |
107,838,182 |
RGD:1624291 |
RGD |
| G |
Ifnb1 |
interferon beta 1, fibroblast |
|
|
IEA |
5 |
107,837,628 |
107,838,182 |
RGD:1600115 |
ENSEMBL |
negative regulation of T-helper 2 cell differentiation
|
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
|
ISO |
11 |
79,006,123 |
79,030,555 |
RGD:1624291 |
RGD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
|
IEA |
11 |
79,006,123 |
79,030,555 |
RGD:1600115 |
ENSEMBL |
| G |
Hlx |
H2.0-like homeobox |
|
|
ISO |
13 |
100,685,757 |
100,691,658 |
RGD:1624291 |
RGD |
| G |
Hlx |
H2.0-like homeobox |
|
|
IEA |
13 |
100,685,757 |
100,691,658 |
RGD:1600115 |
ENSEMBL |
| G |
Socs5 |
suppressor of cytokine signaling 5 |
|
|
ISO |
6 |
10,552,177 |
10,582,783 |
RGD:1624291 |
RGD |
| G |
Socs5 |
suppressor of cytokine signaling 5 |
|
|
IEA |
6 |
10,552,177 |
10,582,783 |
RGD:1600115 |
ENSEMBL |
| G |
Zfp35 |
zinc finger protein 35 |
|
|
ISO |
18 |
15,749,584 |
15,765,238 |
RGD:1624291 |
RGD |
negative regulation of T-helper cell differentiation
|
| G |
Rc3h1 |
ring finger and CCCH-type domains 1 |
|
|
ISO |
13 |
76,493,343 |
76,530,107 |
RGD:1624291 |
RGD |
negative regulation of type I hypersensitivity
|
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
ISO |
13 |
86,809,011 |
86,823,599 |
RGD:1624291 |
RGD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
|
IEA |
13 |
86,809,011 |
86,823,599 |
RGD:1600115 |
ENSEMBL |
negative regulation of type IV hypersensitivity
|
| G |
Il20rb |
interleukin 20 receptor beta |
|
|
ISO |
8 |
105,305,597 |
105,337,224 |
RGD:1624291 |
RGD |
| G |
Il20rb |
interleukin 20 receptor beta |
|
|
IEA |
8 |
105,305,597 |
105,337,224 |
RGD:1600115 |
ENSEMBL |
| G |
Spn |
sialophorin |
|
|
ISO |
1 |
186,388,120 |
186,391,887 |
RGD:1624291 |
RGD |
neutrophil activation involved in immune response
|
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
IEA |
13 |
87,119,464 |
87,123,902 |
RGD:1600115 |
ENSEMBL |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
IEA |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
ENSEMBL |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISS |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
UniProtKB |
| G |
Tyrobp |
Tyro protein tyrosine kinase binding protein |
|
|
ISO |
1 |
85,365,371 |
85,369,224 |
RGD:1624291 |
RGD |
| G |
Tyrobp |
Tyro protein tyrosine kinase binding protein |
|
|
IEA |
1 |
85,365,371 |
85,369,224 |
RGD:1600115 |
ENSEMBL |
neutrophil apoptotic process
|
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
|
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:1624291 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:1624291 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
IEA |
7 |
57,621,756 |
57,625,792 |
RGD:1600115 |
ENSEMBL |
| G |
Il6 |
interleukin 6 |
|
|
ISO |
4 |
456,799 |
461,376 |
RGD:1624291 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISO |
4 |
456,799 |
461,376 |
RGD:1624291 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
IEA |
4 |
456,799 |
461,376 |
RGD:1600115 |
ENSEMBL |
neutrophil clearance
|
| G |
Anxa1 |
annexin A1 |
|
|
IEA |
1 |
223,478,436 |
223,494,455 |
RGD:1600115 |
ENSEMBL |
| G |
Anxa1 |
annexin A1 |
|
|
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:1624291 |
RGD |
neutrophil degranulation
|
| G |
Anxa3 |
annexin A3 |
|
|
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:1624291 |
RGD |
| G |
Myo1f |
myosin IF |
|
|
ISO |
7 |
16,074,714 |
16,125,255 |
RGD:1624291 |
RGD |
| G |
Myo1f |
myosin IF |
|
|
IEA |
7 |
16,074,714 |
16,125,255 |
RGD:1600115 |
ENSEMBL |
| G |
Ppbp |
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
|
|
IEA |
14 |
18,816,434 |
18,817,238 |
RGD:1600115 |
InterPro |
| G |
Stxbp2 |
syntaxin binding protein 2 |
|
|
ISO |
12 |
2,511,793 |
2,522,818 |
RGD:1624291 |
RGD |
| G |
Stxbp2 |
syntaxin binding protein 2 |
|
|
IEA |
12 |
2,511,793 |
2,522,818 |
RGD:1600115 |
ENSEMBL |
| G |
Stxbp3 |
syntaxin binding protein 3 |
|
|
ISO |
2 |
204,395,554 |
204,439,388 |
RGD:1624291 |
RGD |
| G |
Stxbp3 |
syntaxin binding protein 3 |
|
|
IEA |
2 |
204,395,554 |
204,439,388 |
RGD:1600115 |
ENSEMBL |
| G |
Vamp7 |
vesicle-associated membrane protein 7 |
|
|
IDA |
12 |
17,248,700 |
17,278,193 |
|
UniProtKB |
neutrophil homeostasis
|
| G |
Anxa1 |
annexin A1 |
|
|
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:1624291 |
RGD |
| G |
Anxa1 |
annexin A1 |
|
|
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:1624291 |
RGD |
| G |
Jam3 |
junctional adhesion molecule 3 |
|
|
ISO |
8 |
26,697,127 |
26,758,579 |
RGD:1624291 |
RGD |
| G |
Jam3 |
junctional adhesion molecule 3 |
|
|
IEA |
8 |
26,697,127 |
26,758,579 |
RGD:1600115 |
ENSEMBL |
| G |
Mecom |
MDS1 and EVI1 complex locus |
|
|
IEA |
2 |
114,814,409 |
114,882,676 |
RGD:1600115 |
ENSEMBL |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
|
IEA |
5 |
123,158,156 |
123,533,877 |
RGD:1600115 |
ENSEMBL |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
|
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:1624291 |
RGD |
| G |
Pde4b_v3 |
phosphodiesterase 4B, cAMP specific, variant 3 |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
|
|
ISO |
8 |
47,363,896 |
47,369,981 |
RGD:1624291 |
RGD |
| G |
Slc37a4 |
solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
|
|
IEA |
8 |
47,363,896 |
47,369,981 |
RGD:1600115 |
ENSEMBL |
neutrophil mediated immunity
|
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
ISO |
10 |
95,361,338 |
95,381,455 |
RGD:1624291 |
RGD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
|
IEA |
10 |
95,361,338 |
95,381,455 |
RGD:1600115 |
ENSEMBL |
| G |
Kmt2e |
lysine (K)-specific methyltransferase 2E |
|
|
ISO |
4 |
7,042,012 |
7,111,851 |
RGD:1624291 |
RGD |
| G |
Lyst |
lysosomal trafficking regulator |
|
|
ISO |
17 |
66,569,478 |
66,735,402 |
RGD:1624291 |
RGD |
| G |
Myo1f |
myosin IF |
|
|
ISO |
7 |
16,074,714 |
16,125,255 |
RGD:1624291 |
RGD |
neutrophil mediated killing of fungus
|
| G |
Elane |
elastase, neutrophil expressed |
|
|
ISO |
7 |
11,329,642 |
11,331,490 |
RGD:1624291 |
RGD |
| G |
Elane |
elastase, neutrophil expressed |
|
|
IEA |
7 |
11,329,642 |
11,331,490 |
RGD:1600115 |
ENSEMBL |
| G |
Ncf1 |
neutrophil cytosolic factor 1 |
|
|
ISO |
12 |
23,578,097 |
23,587,292 |
RGD:1624291 |
RGD |
| G |
Ncf1 |
neutrophil cytosolic factor 1 |
|
|
IEA |
12 |
23,578,097 |
23,587,292 |
RGD:1600115 |
ENSEMBL |
neutrophil mediated killing of gram-positive bacterium
|
| G |
Ctsg |
cathepsin G |
|
|
ISO |
15 |
34,622,211 |
34,624,798 |
RGD:1624291 |
RGD |
| G |
Ctsg |
cathepsin G |
|
|
IEA |
15 |
34,622,211 |
34,624,798 |
RGD:1600115 |
ENSEMBL |
| G |
Ncf1 |
neutrophil cytosolic factor 1 |
|
|
ISO |
12 |
23,578,097 |
23,587,292 |
RGD:1624291 |
RGD |
| G |
Ncf1 |
neutrophil cytosolic factor 1 |
|
|
IEA |
12 |
23,578,097 |
23,587,292 |
RGD:1600115 |
ENSEMBL |
plasma cell differentiation
|
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
|
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:1624291 |
RGD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
|
IEA |
7 |
116,893,662 |
116,896,768 |
RGD:1600115 |
ENSEMBL |
| G |
Lgals8 |
lectin, galactoside-binding, soluble, 8 |
|
|
ISO |
17 |
68,589,595 |
68,614,014 |
RGD:1624291 |
RGD |
| G |
Nkx2-3 |
NK2 homeobox 3 |
|
|
ISO |
1 |
247,221,087 |
247,224,040 |
RGD:1624291 |
RGD |
| G |
Nkx2-3 |
NK2 homeobox 3 |
|
|
IEA |
1 |
247,221,087 |
247,224,040 |
RGD:1600115 |
ENSEMBL |
positive regulation of activation of membrane attack complex
|
| G |
C3 |
complement component 3 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
C6 |
complement component 6 |
|
|
ISO |
2 |
53,691,290 |
53,764,539 |
RGD:1624291 |
RGD |
positive regulation of complement activation
|
| G |
C6 |
complement component 6 |
|
|
ISO |
2 |
53,691,290 |
53,764,539 |
RGD:1624291 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
|
IDA |
1 |
233,978,931 |
233,983,824 |
RGD:4889148 |
RGD |
positive regulation of dendritic cell cytokine production
|
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
IDA |
19 |
19,662,337 |
19,697,341 |
RGD:1600784 |
RGD |
positive regulation of eosinophil degranulation
|
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
|
ISO |
2 |
25,886,177 |
25,899,128 |
RGD:1624291 |
RGD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
|
IEA |
2 |
25,886,177 |
25,899,128 |
RGD:1600115 |
ENSEMBL |
positive regulation of granzyme A production
|
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
ISO |
13 |
80,691,195 |
80,694,638 |
RGD:1624291 |
RGD |
positive regulation of granzyme B production
|
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
ISO |
13 |
80,691,195 |
80,694,638 |
RGD:1624291 |
RGD |
positive regulation of humoral immune response mediated by circulating immunoglobulin
|
| G |
Fcer2 |
Fc fragment of IgE, low affinity II, receptor for (CD23) |
|
|
ISO |
12 |
2,444,054 |
2,469,678 |
RGD:1624291 |
RGD |
| G |
Fcer2 |
Fc fragment of IgE, low affinity II, receptor for (CD23) |
|
|
IEA |
12 |
2,444,054 |
2,469,678 |
RGD:1600115 |
ENSEMBL |
| G |
Gimap5 |
GTPase, IMAP family member 5 |
|
|
IMP |
4 |
76,836,521 |
76,843,214 |
RGD:2303774 |
RGD |
| G |
Hpx |
hemopexin |
|
|
ISO |
1 |
163,319,509 |
163,327,017 |
RGD:1624291 |
RGD |
| G |
Hpx |
hemopexin |
|
|
IEA |
1 |
163,319,509 |
163,327,017 |
RGD:1600115 |
ENSEMBL |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
|
ISO |
20 |
3,657,842 |
3,659,848 |
RGD:1624291 |
RGD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
|
IEA |
20 |
3,657,842 |
3,659,848 |
RGD:1600115 |
ENSEMBL |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
ISO |
19 |
19,662,337 |
19,697,341 |
RGD:1624291 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
IEA |
19 |
19,662,337 |
19,697,341 |
RGD:1600115 |
ENSEMBL |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
IEA |
13 |
51,246,163 |
51,357,995 |
RGD:1600115 |
ENSEMBL |
| G |
Tnf |
tumor necrosis factor |
|
|
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:1624291 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
IEA |
20 |
3,661,000 |
3,663,618 |
RGD:1600115 |
ENSEMBL |
positive regulation of immune complex clearance by monocytes and macrophages
|
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:1624291 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IEA |
10 |
70,256,263 |
70,258,061 |
RGD:1600115 |
ENSEMBL |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
|
ISS |
8 |
128,892,784 |
128,893,905 |
RGD:1600115 |
BHF-UCL |
positive regulation of immunoglobulin biosynthetic process
|
| G |
Mzb1 |
marginal zone B and B1 cell-specific protein |
|
|
ISO |
18 |
28,261,741 |
28,263,802 |
RGD:1624291 |
RGD |
| G |
Mzb1 |
marginal zone B and B1 cell-specific protein |
|
|
ISO |
18 |
28,261,741 |
28,263,802 |
RGD:1624291 |
RGD |
| G |
Mzb1 |
marginal zone B and B1 cell-specific protein |
|
|
ISS |
18 |
28,261,741 |
28,263,802 |
RGD:1600115 |
UniProtKB |
positive regulation of immunoglobulin mediated immune response
|
| G |
Cd226 |
CD226 molecule |
|
|
ISO |
18 |
86,064,574 |
86,157,909 |
RGD:1624291 |
RGD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
|
ISO |
1 |
79,021,831 |
79,059,686 |
RGD:1624291 |
RGD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
|
IEA |
1 |
79,021,831 |
79,059,686 |
RGD:1600115 |
ENSEMBL |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
ISO |
13 |
77,026,337 |
77,050,223 |
RGD:1624291 |
RGD |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
IEA |
13 |
77,026,337 |
77,050,223 |
RGD:1600115 |
ENSEMBL |
positive regulation of immunoglobulin production
|
| G |
Cd37 |
CD37 molecule |
|
|
ISO |
1 |
95,709,961 |
95,715,116 |
RGD:1624291 |
RGD |
| G |
Cd37 |
CD37 molecule |
|
|
IEA |
1 |
95,709,961 |
95,715,116 |
RGD:1600115 |
ENSEMBL |
| G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
|
|
ISO |
1 |
206,802,745 |
206,806,332 |
RGD:1624291 |
RGD |
| G |
Foxp1 |
forkhead box P1 |
|
|
ISO |
4 |
133,773,373 |
134,007,018 |
RGD:1624291 |
RGD |
| G |
Foxp1 |
forkhead box P1 |
|
|
IBA |
4 |
133,773,373 |
134,007,018 |
RGD:1600115 |
RefGenome |
| G |
Hpx |
hemopexin |
|
|
ISO |
1 |
163,319,509 |
163,327,017 |
RGD:1624291 |
RGD |
| G |
Hpx |
hemopexin |
|
|
IEA |
1 |
163,319,509 |
163,327,017 |
RGD:1600115 |
ENSEMBL |
| G |
Il13 |
interleukin 13 |
|
|
IDA |
10 |
39,093,512 |
39,096,069 |
RGD:633067 |
RGD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
|
IDA |
X |
8,758,662 |
8,820,545 |
RGD:633067 |
RGD |
| G |
Sash3 |
SAM and SH3 domain containing 3 |
|
|
ISO |
X |
134,511,776 |
134,526,489 |
RGD:1624291 |
RGD |
| G |
Sash3 |
SAM and SH3 domain containing 3 |
|
|
IEA |
X |
134,511,776 |
134,526,489 |
RGD:1600115 |
ENSEMBL |
positive regulation of immunoglobulin production in mucosal tissue
|
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
ISO |
13 |
80,691,195 |
80,694,638 |
RGD:1624291 |
RGD |
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
IEA |
13 |
80,691,195 |
80,694,638 |
RGD:1600115 |
ENSEMBL |
positive regulation of isotype switching
|
| G |
Exosc3 |
exosome component 3 |
|
|
ISO |
5 |
61,880,622 |
61,883,825 |
RGD:1624291 |
RGD |
| G |
Exosc6 |
exosome component 6 |
|
|
ISO |
19 |
40,975,037 |
40,976,299 |
RGD:1624291 |
RGD |
| G |
Paxip1 |
PAX interacting (with transcription-activation domain) protein 1 |
|
|
ISO |
4 |
2,790,532 |
2,839,246 |
RGD:1624291 |
RGD |
| G |
Paxip1 |
PAX interacting (with transcription-activation domain) protein 1 |
|
|
IEA |
4 |
2,790,532 |
2,839,246 |
RGD:1600115 |
ENSEMBL |
positive regulation of isotype switching to IgA isotypes
|
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:1624291 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
IEA |
1 |
80,894,705 |
80,911,020 |
RGD:1600115 |
ENSEMBL |
| G |
Tnfsf13 |
tumor necrosis factor (ligand) superfamily, member 13 |
|
|
ISO |
10 |
56,499,945 |
56,502,928 |
RGD:1624291 |
RGD |
| G |
Tnfsf13 |
tumor necrosis factor (ligand) superfamily, member 13 |
|
|
ISO |
10 |
56,499,945 |
56,502,928 |
RGD:1624291 |
RGD |
positive regulation of isotype switching to IgE isotypes
|
| G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
|
|
ISO |
1 |
206,802,745 |
206,806,332 |
RGD:1624291 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:1624291 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
IEA |
10 |
39,074,582 |
39,080,134 |
RGD:1600115 |
ENSEMBL |
| G |
Stat6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
|
|
ISO |
7 |
67,623,534 |
67,642,283 |
RGD:1624291 |
RGD |
| G |
Stat6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
|
|
IEA |
7 |
67,623,534 |
67,642,283 |
RGD:1600115 |
ENSEMBL |
positive regulation of isotype switching to IgG isotypes
|
| G |
Cd28 |
Cd28 molecule |
|
|
ISO |
9 |
59,342,273 |
59,367,743 |
RGD:1624291 |
RGD |
| G |
Cd28 |
Cd28 molecule |
|
|
IEA |
9 |
59,342,273 |
59,367,743 |
RGD:1600115 |
ENSEMBL |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
IDA |
3 |
156,092,602 |
156,107,427 |
RGD:2290270 |
MGI |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:1624291 |
RGD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
IEA |
3 |
156,092,602 |
156,107,427 |
RGD:1600115 |
ENSEMBL |
| G |
Ifng |
interferon gamma |
|
|
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:1624291 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
IEA |
7 |
57,621,756 |
57,625,792 |
RGD:1600115 |
ENSEMBL |
| G |
Il2 |
interleukin 2 |
|
|
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:1624291 |
RGD |
| G |
Il2 |
interleukin 2 |
|
|
IEA |
2 |
123,655,005 |
123,659,709 |
RGD:1600115 |
ENSEMBL |
| G |
Il4 |
interleukin 4 |
|
|
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:1624291 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:1624291 |
RGD |
| G |
Il4 |
interleukin 4 |
|
|
IEA |
10 |
39,074,582 |
39,080,134 |
RGD:1600115 |
ENSEMBL |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
IEA |
13 |
51,246,163 |
51,357,995 |
RGD:1600115 |
ENSEMBL |
| G |
Tbx21 |
T-box 21 |
|
|
ISO |
10 |
85,817,743 |
85,834,178 |
RGD:1624291 |
RGD |
| G |
Tbx21 |
T-box 21 |
|
|
IEA |
10 |
85,817,743 |
85,834,178 |
RGD:1600115 |
ENSEMBL |
positive regulation of macrophage cytokine production
|
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:1624291 |
RGD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
|
ISO |
18 |
56,756,511 |
56,765,711 |
RGD:1624291 |
RGD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
|
ISS |
18 |
56,756,511 |
56,765,711 |
RGD:1600115 |
BHF-UCL |
| G |
Sema7a |
semaphorin 7A, GPI membrane anchor |
|
|
ISO |
8 |
61,717,449 |
61,739,529 |
RGD:1624291 |
RGD |
| G |
Sema7a |
semaphorin 7A, GPI membrane anchor |
|
|
IEA |
8 |
61,717,449 |
61,739,529 |
RGD:1600115 |
ENSEMBL |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISO |
2 |
175,607,990 |
175,613,992 |
RGD:1624291 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
IEA |
2 |
175,607,990 |
175,613,992 |
RGD:1600115 |
ENSEMBL |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:1624291 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
IEA |
5 |
83,564,100 |
83,577,735 |
RGD:1600115 |
ENSEMBL |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
|
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:1624291 |
RGD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
|
IEA |
16 |
3,782,025 |
3,799,625 |
RGD:1600115 |
ENSEMBL |
positive regulation of mast cell cytokine production
|
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
IEA |
13 |
87,119,464 |
87,123,902 |
RGD:1600115 |
ENSEMBL |
positive regulation of mast cell degranulation
|
| G |
Adora2b |
adenosine A2B receptor |
|
|
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:1624291 |
RGD |
| G |
Adora2b |
adenosine A2B receptor |
|
|
IEA |
10 |
48,421,592 |
48,437,967 |
RGD:1600115 |
ENSEMBL |
| G |
Adora3 |
adenosine A3 receptor |
|
|
ISO |
2 |
201,157,782 |
201,161,425 |
RGD:1624291 |
RGD |
| G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
|
IMP |
10 |
93,312,405 |
93,354,229 |
RGD:5130941 |
RGD |
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
|
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
IEA |
13 |
87,119,464 |
87,123,902 |
RGD:1600115 |
ENSEMBL |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
|
ISO |
5 |
152,119,455 |
152,147,057 |
RGD:1624291 |
RGD |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
|
ISS |
5 |
152,119,455 |
152,147,057 |
RGD:1600115 |
UniProtKB |
| G |
Gab2 |
GRB2-associated binding protein 2 |
|
|
ISO |
1 |
154,348,777 |
154,544,906 |
RGD:1624291 |
RGD |
| G |
Gab2 |
GRB2-associated binding protein 2 |
|
|
ISS |
1 |
154,348,777 |
154,544,906 |
RGD:1600115 |
UniProtKB |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Ms4a2 |
membrane-spanning 4-domains, subfamily A, member 2 |
|
|
IMP |
1 |
214,011,050 |
214,018,999 |
RGD:1578516 |
RGD |
| G |
Pld2 |
phospholipase D2 |
|
|
IMP |
10 |
57,388,474 |
57,439,063 |
RGD:2299903 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
IMP |
17 |
18,440,672 |
18,498,001 |
RGD:2299903 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
IEA |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
ENSEMBL |
positive regulation of memory T cell differentiation
|
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
|
ISO |
7 |
1,584,112 |
1,586,226 |
RGD:1624291 |
RGD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
|
IEA |
7 |
1,584,112 |
1,586,226 |
RGD:1600115 |
ENSEMBL |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
ISO |
13 |
77,026,337 |
77,050,223 |
RGD:1624291 |
RGD |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
IEA |
13 |
77,026,337 |
77,050,223 |
RGD:1600115 |
ENSEMBL |
positive regulation of myeloid leukocyte cytokine production involved in immune response
|
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISO |
20 |
13,191,986 |
13,192,851 |
RGD:1624291 |
RGD |
positive regulation of natural killer cell cytokine production
|
| G |
Gimap5 |
GTPase, IMAP family member 5 |
|
|
IMP |
4 |
76,836,521 |
76,843,214 |
RGD:2303778 |
RGD |
| G |
Il21 |
interleukin 21 |
|
|
ISO |
2 |
123,774,331 |
123,781,697 |
RGD:1624291 |
RGD |
| G |
Il21 |
interleukin 21 |
|
|
IEA |
2 |
123,774,331 |
123,781,697 |
RGD:1600115 |
ENSEMBL |
positive regulation of natural killer cell mediated cytotoxicity
|
| G |
Cadm1 |
cell adhesion molecule 1 |
|
|
ISO |
8 |
50,765,645 |
51,108,962 |
RGD:1624291 |
RGD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
|
ISO |
8 |
50,765,645 |
51,108,962 |
RGD:1624291 |
RGD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
|
ISS |
8 |
50,765,645 |
51,108,962 |
RGD:1600115 |
UniProtKB |
| G |
Cd226 |
CD226 molecule |
|
|
ISO |
18 |
86,064,574 |
86,157,909 |
RGD:1624291 |
RGD |
| G |
Crtam |
cytotoxic and regulatory T cell molecule |
|
|
ISO |
8 |
43,943,971 |
43,981,609 |
RGD:1624291 |
RGD |
| G |
Crtam |
cytotoxic and regulatory T cell molecule |
|
|
ISO |
8 |
43,943,971 |
43,981,609 |
RGD:1624291 |
RGD |
| G |
Gimap5 |
GTPase, IMAP family member 5 |
|
|
IMP |
4 |
76,836,521 |
76,843,214 |
RGD:2303778 |
RGD |
| G |
Il12a |
interleukin 12A |
|
|
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:1624291 |
RGD |
| G |
Il21 |
interleukin 21 |
|
|
ISO |
2 |
123,774,331 |
123,781,697 |
RGD:1624291 |
RGD |
| G |
Il21 |
interleukin 21 |
|
|
IEA |
2 |
123,774,331 |
123,781,697 |
RGD:1600115 |
ENSEMBL |
| G |
Klre1 |
killer cell lectin-like receptor, family E, member 1 |
|
|
ISO |
4 |
166,857,685 |
166,864,221 |
RGD:1624291 |
RGD |
| G |
Klre1 |
killer cell lectin-like receptor, family E, member 1 |
|
|
IEA |
4 |
166,857,685 |
166,864,221 |
RGD:1600115 |
ENSEMBL |
| G |
Klrk1 |
killer cell lectin-like receptor subfamily K, member 1 |
|
|
ISO |
4 |
166,914,786 |
166,922,659 |
RGD:1624291 |
RGD |
| G |
Klrk1 |
killer cell lectin-like receptor subfamily K, member 1 |
|
|
IEA |
4 |
166,914,786 |
166,922,659 |
RGD:1600115 |
ENSEMBL |
| G |
Lag3 |
lymphocyte-activation gene 3 |
|
|
ISO |
4 |
161,031,506 |
161,039,255 |
RGD:1624291 |
RGD |
| G |
Lag3 |
lymphocyte-activation gene 3 |
|
|
IEA |
4 |
161,031,506 |
161,039,255 |
RGD:1600115 |
ENSEMBL |
| G |
Ly49s3 |
Ly-49 stimulatory receptor 3 |
|
|
IDA |
4 |
168,023,598 |
168,209,373 |
RGD:633264 |
RGD |
| G |
Ncr3 |
natural cytotoxicity triggering receptor 3 |
|
|
IEA |
20 |
3,701,807 |
3,707,278 |
RGD:1600115 |
ENSEMBL |
| G |
PVR |
poliovirus receptor |
|
|
ISO |
1 |
79,213,654 |
79,229,063 |
RGD:1624291 |
RGD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
|
ISO |
1 |
79,021,831 |
79,059,686 |
RGD:1624291 |
RGD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:1624291 |
RGD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
IEA |
20 |
1,412,553 |
1,416,692 |
RGD:1600115 |
ENSEMBL |
| G |
Sh2d1a |
SH2 domain containing 1A |
|
|
ISO |
X |
2,532,295 |
2,560,524 |
RGD:1624291 |
RGD |
| G |
Sh2d1a |
SH2 domain containing 1A |
|
|
IEA |
X |
2,532,295 |
2,560,524 |
RGD:1600115 |
ENSEMBL |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
|
ISO |
10 |
89,795,404 |
89,819,732 |
RGD:1624291 |
RGD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
|
IEA |
10 |
89,795,404 |
89,819,732 |
RGD:1600115 |
ENSEMBL |
| G |
Stat5b |
signal transducer and activator of transcription 5B |
|
|
ISO |
10 |
89,716,624 |
89,743,134 |
RGD:1624291 |
RGD |
| G |
Stat5b |
signal transducer and activator of transcription 5B |
|
|
IEA |
10 |
89,716,624 |
89,743,134 |
RGD:1600115 |
ENSEMBL |
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target
|
| G |
Cd226 |
CD226 molecule |
|
|
ISO |
18 |
86,064,574 |
86,157,909 |
RGD:1624291 |
RGD |
| G |
Crtam |
cytotoxic and regulatory T cell molecule |
|
|
ISO |
8 |
43,943,971 |
43,981,609 |
RGD:1624291 |
RGD |
| G |
Crtam |
cytotoxic and regulatory T cell molecule |
|
|
IEA |
8 |
43,943,971 |
43,981,609 |
RGD:1600115 |
ENSEMBL |
| G |
Crtam |
cytotoxic and regulatory T cell molecule |
|
|
ISO |
8 |
43,943,971 |
43,981,609 |
RGD:1624291 |
RGD |
| G |
Il12a |
interleukin 12A |
|
|
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:1624291 |
RGD |
| G |
Il12a |
interleukin 12A |
|
|
IEA |
2 |
158,710,261 |
158,717,689 |
RGD:1600115 |
ENSEMBL |
| G |
Il12b |
interleukin 12B |
|
|
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:1624291 |
RGD |
| G |
PVR |
poliovirus receptor |
|
|
ISO |
1 |
79,213,654 |
79,229,063 |
RGD:1624291 |
RGD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
|
ISO |
1 |
79,021,831 |
79,059,686 |
RGD:1624291 |
RGD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
|
IEA |
1 |
79,021,831 |
79,059,686 |
RGD:1600115 |
ENSEMBL |
positive regulation of natural killer cell mediated immunity
|
| G |
Sh2d1b |
SH2 domain containing 1B |
|
|
ISO |
13 |
86,096,465 |
86,126,881 |
RGD:1624291 |
RGD |
positive regulation of neutrophil apoptotic process
|
| G |
Anxa1 |
annexin A1 |
|
|
IEA |
1 |
223,478,436 |
223,494,455 |
RGD:1600115 |
ENSEMBL |
| G |
Anxa1 |
annexin A1 |
|
|
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:1624291 |
RGD |
| G |
Cd44 |
Cd44 molecule |
|
|
IMP |
3 |
88,022,962 |
88,110,352 |
RGD:2289387 |
RGD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
|
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:1624291 |
RGD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
|
ISS |
12 |
33,863,876 |
33,864,958 |
RGD:1600115 |
UniProtKB |
positive regulation of neutrophil mediated killing of gram-negative bacterium
|
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
|
ISO |
2 |
25,886,177 |
25,899,128 |
RGD:1624291 |
RGD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
|
IEA |
2 |
25,886,177 |
25,899,128 |
RGD:1600115 |
ENSEMBL |
positive regulation of peripheral T cell tolerance induction
|
| G |
Foxp3 |
forkhead box P3 |
|
|
ISO |
X |
26,950,006 |
26,965,329 |
RGD:1624291 |
RGD |
| G |
Foxp3 |
forkhead box P3 |
|
|
IBA |
X |
26,950,006 |
26,965,329 |
RGD:1600115 |
RefGenome |
positive regulation of prostaglandin secretion involved in immune response
|
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
ISO |
20 |
13,191,986 |
13,192,851 |
RGD:1624291 |
RGD |
positive regulation of respiratory burst involved in inflammatory response
|
| G |
Lbp |
lipopolysaccharide binding protein |
|
|
ISO |
3 |
149,016,605 |
149,043,530 |
RGD:1624291 |
RGD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
|
IEA |
3 |
149,016,605 |
149,043,530 |
RGD:1600115 |
ENSEMBL |
| G |
Rps19 |
ribosomal protein S19 |
|
|
ISO |
1 |
80,176,649 |
80,182,351 |
RGD:1624291 |
RGD |
positive regulation of T cell cytokine production
|
| G |
Malt1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
|
IEA |
18 |
61,708,388 |
61,760,004 |
RGD:1600115 |
ENSEMBL |
| G |
Malt1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
|
|
ISO |
18 |
61,708,388 |
61,760,004 |
RGD:1624291 |
RGD |
| G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
|
|
ISO |
5 |
48,252,637 |
48,308,820 |
RGD:1624291 |
RGD |
| G |
Sash3 |
SAM and SH3 domain containing 3 |
|
|
ISO |
X |
134,511,776 |
134,526,489 |
RGD:1624291 |
RGD |
| G |
Sash3 |
SAM and SH3 domain containing 3 |
|
|
IEA |
X |
134,511,776 |
134,526,489 |
RGD:1600115 |
ENSEMBL |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
ISO |
13 |
77,026,337 |
77,050,223 |
RGD:1624291 |
RGD |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
ISO |
13 |
77,026,337 |
77,050,223 |
RGD:1624291 |
RGD |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
IEA |
13 |
77,026,337 |
77,050,223 |
RGD:1600115 |
ENSEMBL |
| G |
Traf2 |
Tnf receptor-associated factor 2 |
|
|
ISO |
3 |
3,692,740 |
3,717,332 |
RGD:1624291 |
RGD |
| G |
Traf2 |
Tnf receptor-associated factor 2 |
|
|
IEA |
3 |
3,692,740 |
3,717,332 |
RGD:1600115 |
ENSEMBL |
| G |
Traf6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
|
IEA |
3 |
86,827,582 |
86,847,408 |
RGD:1600115 |
ENSEMBL |
| G |
Traf6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
|
ISO |
3 |
86,827,582 |
86,847,408 |
RGD:1624291 |
RGD |
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
ISO |
13 |
80,691,195 |
80,694,638 |
RGD:1624291 |
RGD |
positive regulation of T cell homeostatic proliferation
|
| G |
Cd24 |
CD24 molecule |
|
|
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:1624291 |
RGD |
| G |
Cd24 |
CD24 molecule |
|
|
IEA |
20 |
47,502,354 |
47,507,663 |
RGD:1600115 |
ENSEMBL |
positive regulation of T cell mediated cytotoxicity
|
| G |
Abcb9 |
ATP-binding cassette, subfamily B (MDR/TAP), member 9 |
|
|
IBA |
12 |
33,623,383 |
33,656,242 |
RGD:1600115 |
RefGenome |
| G |
B2m |
beta-2 microglobulin |
|
|
ISO |
3 |
108,927,919 |
108,932,718 |
RGD:1624291 |
RGD |
| G |
B2m |
beta-2 microglobulin |
|
|
IEA |
3 |
108,927,919 |
108,932,718 |
RGD:1600115 |
ENSEMBL |
| G |
Cd1d1 |
CD1d1 molecule |
|
|
ISO |
2 |
179,011,165 |
179,014,672 |
RGD:1624291 |
RGD |
| G |
Hspa1b |
heat shock protein 1B |
|
|
IDA |
20 |
3,955,274 |
3,957,748 |
RGD:1298959 |
RGD |
| G |
Il12a |
interleukin 12A |
|
|
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:1624291 |
RGD |
| G |
Il12a |
interleukin 12A |
|
|
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:1624291 |
RGD |
| G |
Il12a |
interleukin 12A |
|
|
IEA |
2 |
158,710,261 |
158,717,689 |
RGD:1600115 |
ENSEMBL |
| G |
Il12b |
interleukin 12B |
|
|
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:1624291 |
RGD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
|
ISO |
7 |
1,584,112 |
1,586,226 |
RGD:1624291 |
RGD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
|
IEA |
7 |
1,584,112 |
1,586,226 |
RGD:1600115 |
ENSEMBL |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
|
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:1624291 |
RGD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
|
IEA |
12 |
35,074,025 |
35,117,152 |
RGD:1600115 |
ENSEMBL |
| G |
Pnp |
purine nucleoside phosphorylase |
|
|
ISO |
15 |
26,929,784 |
26,937,434 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
IEA |
13 |
51,246,163 |
51,357,995 |
RGD:1600115 |
ENSEMBL |
| G |
RT1-A1 |
RT1 class Ia, locus A1 |
|
|
IDA |
20 |
5,056,763 |
5,060,280 |
RGD:2313503 |
RGD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
|
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:1624291 |
RGD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:1624291 |
RGD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:1624291 |
RGD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:1624291 |
RGD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:1624291 |
RGD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
|
IEA |
20 |
1,412,553 |
1,416,692 |
RGD:1600115 |
ENSEMBL |
| G |
RT1-S3 |
RT1 class Ib, locus S3 |
|
|
ISO |
20 |
2,815,943 |
2,820,644 |
RGD:1624291 |
RGD |
| G |
Tap1 |
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
|
|
IBA |
20 |
4,790,363 |
4,800,730 |
RGD:1600115 |
RefGenome |
| G |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
|
|
ISO |
20 |
4,770,446 |
4,784,488 |
RGD:1624291 |
RGD |
| G |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
|
|
ISO |
20 |
4,770,446 |
4,784,488 |
RGD:1624291 |
RGD |
| G |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
|
|
IDA |
20 |
4,770,446 |
4,784,488 |
RGD:1299069 |
MGI |
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
ISO |
13 |
80,691,195 |
80,694,638 |
RGD:1624291 |
RGD |
positive regulation of T cell mediated immune response to tumor cell
|
| G |
Cd24 |
CD24 molecule |
|
|
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:1624291 |
RGD |
| G |
Cd24 |
CD24 molecule |
|
|
IEA |
20 |
47,502,354 |
47,507,663 |
RGD:1600115 |
ENSEMBL |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
|
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:1624291 |
RGD |
positive regulation of T cell mediated immunity
|
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
positive regulation of T-helper 1 cell cytokine production
|
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
ISO |
13 |
80,691,195 |
80,694,638 |
RGD:1624291 |
RGD |
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
IEA |
13 |
80,691,195 |
80,694,638 |
RGD:1600115 |
ENSEMBL |
positive regulation of T-helper 1 cell differentiation
|
| G |
Hlx |
H2.0-like homeobox |
|
|
ISO |
13 |
100,685,757 |
100,691,658 |
RGD:1624291 |
RGD |
| G |
Hlx |
H2.0-like homeobox |
|
|
IEA |
13 |
100,685,757 |
100,691,658 |
RGD:1600115 |
ENSEMBL |
| G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
|
|
ISO |
5 |
30,714,817 |
30,745,941 |
RGD:1624291 |
RGD |
| G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
|
|
IEA |
5 |
30,714,817 |
30,745,941 |
RGD:1600115 |
ENSEMBL |
| G |
Socs5 |
suppressor of cytokine signaling 5 |
|
|
ISO |
6 |
10,552,177 |
10,582,783 |
RGD:1624291 |
RGD |
| G |
Socs5 |
suppressor of cytokine signaling 5 |
|
|
IEA |
6 |
10,552,177 |
10,582,783 |
RGD:1600115 |
ENSEMBL |
positive regulation of T-helper 17 cell lineage commitment
|
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
|
ISO |
7 |
1,584,112 |
1,586,226 |
RGD:1624291 |
RGD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
|
IEA |
7 |
1,584,112 |
1,586,226 |
RGD:1600115 |
ENSEMBL |
positive regulation of T-helper 2 cell cytokine production
|
| G |
Prkcz |
protein kinase C, zeta |
|
|
ISO |
5 |
172,061,825 |
172,172,793 |
RGD:1624291 |
RGD |
| G |
Prkcz |
protein kinase C, zeta |
|
|
ISS |
5 |
172,061,825 |
172,172,793 |
RGD:1600115 |
UniProtKB |
| G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
|
ISS |
6 |
44,100,775 |
44,113,910 |
RGD:1600115 |
UniProtKB |
| G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
|
ISO |
6 |
44,100,775 |
44,113,910 |
RGD:1624291 |
RGD |
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
ISO |
13 |
80,691,195 |
80,694,638 |
RGD:1624291 |
RGD |
| G |
Xcl1 |
chemokine (C motif) ligand 1 |
|
|
IEA |
13 |
80,691,195 |
80,694,638 |
RGD:1600115 |
ENSEMBL |
positive regulation of T-helper 2 cell differentiation
|
| G |
Il4r |
interleukin 4 receptor |
|
|
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:1624291 |
RGD |
| G |
Il4r |
interleukin 4 receptor |
|
|
IEA |
1 |
184,612,903 |
184,637,863 |
RGD:1600115 |
ENSEMBL |
| G |
Il6 |
interleukin 6 |
|
|
ISO |
4 |
456,799 |
461,376 |
RGD:1624291 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
IEA |
4 |
456,799 |
461,376 |
RGD:1600115 |
ENSEMBL |
| G |
Prkcz |
protein kinase C, zeta |
|
|
ISO |
5 |
172,061,825 |
172,172,793 |
RGD:1624291 |
RGD |
| G |
Prkcz |
protein kinase C, zeta |
|
|
ISS |
5 |
172,061,825 |
172,172,793 |
RGD:1600115 |
UniProtKB |
| G |
Rara |
retinoic acid receptor, alpha |
|
|
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:1624291 |
RGD |
| G |
Rara |
retinoic acid receptor, alpha |
|
|
IEA |
10 |
87,740,479 |
87,753,265 |
RGD:1600115 |
ENSEMBL |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
ISO |
13 |
77,026,337 |
77,050,223 |
RGD:1624291 |
RGD |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
|
IEA |
13 |
77,026,337 |
77,050,223 |
RGD:1600115 |
ENSEMBL |
positive regulation of type I hypersensitivity
|
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
|
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
IEA |
13 |
87,119,464 |
87,123,902 |
RGD:1600115 |
ENSEMBL |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Ighe |
immunoglobulin heavy chain (epsilon polypeptide) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
positive regulation of type IIa hypersensitivity
|
| G |
C3 |
complement component 3 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
IEA |
13 |
87,119,464 |
87,123,902 |
RGD:1600115 |
ENSEMBL |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
|
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:1624291 |
RGD |
positive regulation of type III hypersensitivity
|
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:1624291 |
RGD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
|
IEA |
13 |
87,119,464 |
87,123,902 |
RGD:1600115 |
ENSEMBL |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
|
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:1624291 |
RGD |
positive regulation of type IV hypersensitivity
|
| G |
Zp3 |
zona pellucida glycoprotein 3 (sperm receptor) |
|
|
ISO |
12 |
21,805,746 |
21,812,711 |
RGD:1624291 |
RGD |
| G |
Zp3 |
zona pellucida glycoprotein 3 (sperm receptor) |
|
|
IEA |
12 |
21,805,746 |
21,812,711 |
RGD:1600115 |
ENSEMBL |
| G |
Zp3 |
zona pellucida glycoprotein 3 (sperm receptor) |
|
|
ISS |
12 |
21,805,746 |
21,812,711 |
RGD:1600115 |
UniProtKB |
protection from natural killer cell mediated cytotoxicity
|
| G |
Clec2d |
C-type lectin domain family 2, member D |
|
|
ISO |
4 |
165,998,313 |
166,008,311 |
RGD:1624291 |
RGD |
| G |
Clec2d |
C-type lectin domain family 2, member D |
|
|
ISO |
4 |
165,998,313 |
166,008,311 |
RGD:1624291 |
RGD |
| G |
Clec2d |
C-type lectin domain family 2, member D |
|
|
ISO |
4 |
165,998,313 |
166,008,311 |
RGD:1624291 |
RGD |
| G |
Tap1 |
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
|
|
IMP |
20 |
4,790,363 |
4,800,730 |
RGD:2312378 |
RGD |
| G |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
|
|
IMP |
20 |
4,770,446 |
4,784,488 |
RGD:2312378 |
RGD |
regulation of complement activation, classical pathway
|
| G |
Cd55 |
Cd55 molecule |
|
|
ISO |
13 |
43,322,246 |
43,348,334 |
RGD:1624291 |
RGD |
regulation of humoral immune response mediated by circulating immunoglobulin
|
| G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
|
|
ISO |
13 |
51,246,163 |
51,357,995 |
RGD:1624291 |
RGD |
regulation of immunoglobulin production
|
| G |
Foxp3 |
forkhead box P3 |
|
|
ISO |
X |
26,950,006 |
26,965,329 |
RGD:1624291 |
RGD |
regulation of immunoglobulin secretion
|
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
IDA |
3 |
156,092,602 |
156,107,427 |
RGD:2290270 |
MGI |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
|
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:1624291 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
ISO |
X |
141,925,019 |
141,937,183 |
RGD:1624291 |
RGD |
| G |
Cd40lg |
CD40 ligand |
|
|
IEA |
X |
141,925,019 |
141,937,183 |
RGD:1600115 |
ENSEMBL |
| G |
Tnf |
tumor necrosis factor |
|
|
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:1624291 |
RGD |
| G |
Traf2 |
Tnf receptor-associated factor 2 |
|
|
ISO |
3 |
3,692,740 |
3,717,332 |
RGD:1624291 |
RGD |
| G |
Traf6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
|
ISO |
3 |
86,827,582 |
86,847,408 |
RGD:1624291 |
RGD |
regulation of isotype switching to IgG isotypes
|
| G |
Foxp3 |
forkhead box P3 |
|
|
ISO |
X |
26,950,006 |
26,965,329 |
RGD:1624291 |
RGD |
| G |
Foxp3 |
forkhead box P3 |
|
|
IBA |
X |
26,950,006 |
26,965,329 |
RGD:1600115 |
RefGenome |
| G |
Il27ra |
interleukin 27 receptor, alpha |
|
|
ISO |
19 |
25,795,355 |
25,807,317 |
RGD:1624291 |
RGD |
| G |
Il27ra |
interleukin 27 receptor, alpha |
|
|
IEA |
19 |
25,795,355 |
25,807,317 |
RGD:1600115 |
ENSEMBL |
| G |
Ndfip1 |
Nedd4 family interacting protein 1 |
|
|
ISO |
18 |
31,351,538 |
31,401,736 |
RGD:1624291 |
RGD |
| G |
Ndfip1 |
Nedd4 family interacting protein 1 |
|
|
IEA |
18 |
31,351,538 |
31,401,736 |
RGD:1600115 |
ENSEMBL |
regulation of mast cell apoptotic process
|
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
|
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:1624291 |
RGD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
|
IEA |
6 |
41,882,432 |
41,930,755 |
RGD:1600115 |
ENSEMBL |
regulation of mast cell degranulation
|
| G |
Fes |
feline sarcoma oncogene |
|
|
ISO |
1 |
136,199,523 |
136,208,759 |
RGD:1624291 |
RGD |
| G |
Fes |
feline sarcoma oncogene |
|
|
IEA |
1 |
136,199,523 |
136,208,759 |
RGD:1600115 |
ENSEMBL |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISS |
5 |
16,933,111 |
17,054,564 |
RGD:1600115 |
UniProtKB |
| G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
|
|
ISO |
10 |
13,329,708 |
13,394,080 |
RGD:1624291 |
RGD |
| G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
|
|
IEA |
10 |
13,329,708 |
13,394,080 |
RGD:1600115 |
ENSEMBL |
| G |
Stxbp2 |
syntaxin binding protein 2 |
|
|
IMP |
12 |
2,511,793 |
2,522,818 |
RGD:2312429 |
RGD |
| G |
Unc13d |
unc-13 homolog D (C. elegans) |
|
|
ISO |
10 |
106,170,475 |
106,185,215 |
RGD:1624291 |
RGD |
| G |
Unc13d |
unc-13 homolog D (C. elegans) |
|
|
IEA |
10 |
106,170,475 |
106,185,215 |
RGD:1600115 |
ENSEMBL |
regulation of memory T cell differentiation
|
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
|
ISO |
11 |
79,006,123 |
79,030,555 |
RGD:1624291 |
RGD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
|
IEA |
11 |
79,006,123 |
79,030,555 |
RGD:1600115 |
ENSEMBL |
regulation of neutrophil degranulation
|
| G |
Pram1 |
PML-RARA regulated adaptor molecule 1 |
|
|
ISO |
7 |
16,143,455 |
16,149,438 |
RGD:1624291 |
RGD |
| G |
Pram1 |
PML-RARA regulated adaptor molecule 1 |
|
|
IEA |
7 |
16,143,455 |
16,149,438 |
RGD:1600115 |
ENSEMBL |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISO |
17 |
18,440,672 |
18,498,001 |
RGD:1624291 |
RGD |
| G |
Syk |
spleen tyrosine kinase |
|
|
IEA |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
ENSEMBL |
| G |
Syk |
spleen tyrosine kinase |
|
|
ISS |
17 |
18,440,672 |
18,498,001 |
RGD:1600115 |
UniProtKB |
regulation of neutrophil mediated killing of gram-negative bacterium
|
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
|
IEA |
14 |
18,825,357 |
18,826,269 |
RGD:1600115 |
ENSEMBL |
regulation of T cell cytokine production
|
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
|
ISO |
1 |
95,773,485 |
95,803,542 |
RGD:1624291 |
RGD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
|
ISS |
1 |
95,773,485 |
95,803,542 |
RGD:1600115 |
UniProtKB |
regulation of T cell homeostatic proliferation
|
| G |
Il2 |
interleukin 2 |
|
|
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:1624291 |
RGD |
| G |
Il2 |
interleukin 2 |
|
|
IEA |
2 |
123,655,005 |
123,659,709 |
RGD:1600115 |
ENSEMBL |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
|
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:1624291 |
RGD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
|
IEA |
17 |
78,050,491 |
78,097,802 |
RGD:1600115 |
ENSEMBL |
regulation of T cell mediated immunity
|
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
|
IMP |
3 |
44,279,255 |
44,360,283 |
RGD:1626458 |
RGD |
regulation of T-helper 1 cell differentiation
|
| G |
Il27 |
interleukin 27 |
|
|
IEA |
1 |
185,730,394 |
185,735,604 |
RGD:1600115 |
ENSEMBL |
| G |
Il27 |
interleukin 27 |
|
|
ISO |
1 |
185,730,394 |
185,735,604 |
RGD:1624291 |
RGD |
regulation of T-helper cell differentiation
|
| G |
Il12rb2 |
interleukin 12 receptor, beta 2 |
|
|
NAS |
4 |
96,929,755 |
96,995,733 |
RGD:1331512 |
RGD |
respiratory burst after phagocytosis
|
| G |
Selk |
selenoprotein K |
|
|
ISO |
16 |
5,306,405 |
5,314,721 |
RGD:1624291 |
RGD |
respiratory burst involved in defense response
|
| G |
Mpo |
myeloperoxidase |
|
|
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:1624291 |
RGD |
| G |
Mpo |
myeloperoxidase |
|
|
IEA |
10 |
76,085,872 |
76,097,012 |
RGD:1600115 |
ENSEMBL |
| G |
Ncf1 |
neutrophil cytosolic factor 1 |
|
|
ISO |
12 |
23,578,097 |
23,587,292 |
RGD:1624291 |
RGD |
| G |
Ncf1 |
neutrophil cytosolic factor 1 |
|
|
IEA |
12 |
23,578,097 |
23,587,292 |
RGD:1600115 |
ENSEMBL |
respiratory burst involved in inflammatory response
|
| G |
Prdx2 |
peroxiredoxin 2 |
|
|
ISO |
19 |
24,836,199 |
24,841,390 |
RGD:1624291 |
RGD |
somatic diversification of immunoglobulins
|
| G |
aicda |
activation-induced cytidine deaminase |
|
|
ISO |
4 |
159,006,328 |
159,017,501 |
RGD:1624291 |
RGD |
| G |
Ctnnbl1 |
catenin, beta like 1 |
|
|
ISO |
3 |
148,440,757 |
148,602,378 |
RGD:1624291 |
RGD |
| G |
Ctnnbl1 |
catenin, beta like 1 |
|
|
IEA |
3 |
148,440,757 |
148,602,378 |
RGD:1600115 |
ENSEMBL |
somatic hypermutation of immunoglobulin genes
|
| G |
Exo1 |
exonuclease 1 |
|
|
ISO |
13 |
91,619,024 |
91,644,366 |
RGD:1624291 |
RGD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:1624291 |
RGD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:1624291 |
RGD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
IEA |
8 |
115,616,396 |
115,653,471 |
RGD:1600115 |
ENSEMBL |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
IBA |
8 |
115,616,396 |
115,653,471 |
RGD:1600115 |
RefGenome |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
NOT |
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
IEA |
6 |
11,199,906 |
11,258,350 |
RGD:1600115 |
ENSEMBL |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
IBA |
6 |
11,199,906 |
11,258,350 |
RGD:1600115 |
RefGenome |
| G |
Msh3 |
mutS homolog 3 (E. coli) |
|
NOT |
ISO |
2 |
22,462,934 |
22,606,874 |
RGD:1624291 |
RGD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
|
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:1624291 |
RGD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
|
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:1624291 |
RGD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
|
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:1624291 |
RGD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
|
IBA |
12 |
11,004,507 |
11,028,754 |
RGD:1600115 |
RefGenome |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
|
ISO |
12 |
11,004,507 |
11,028,754 |
RGD:1624291 |
RGD |
| G |
Polm |
polymerase (DNA directed), mu |
|
|
ISO |
14 |
86,491,716 |
86,501,294 |
RGD:1624291 |
RGD |
| G |
Polm |
polymerase (DNA directed), mu |
|
|
IEA |
14 |
86,491,716 |
86,501,294 |
RGD:1600115 |
ENSEMBL |
| G |
Ung |
uracil-DNA glycosylase |
|
|
ISO |
12 |
43,520,629 |
43,528,873 |
RGD:1624291 |
RGD |
somatic recombination of immunoglobulin gene segments
|
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
| G |
Msh3 |
mutS homolog 3 (E. coli) |
|
|
ISO |
2 |
22,462,934 |
22,606,874 |
RGD:1624291 |
RGD |
| G |
Msh3 |
mutS homolog 3 (E. coli) |
|
|
IBA |
2 |
22,462,934 |
22,606,874 |
RGD:1600115 |
RefGenome |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
|
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:1624291 |
RGD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
|
IEA |
12 |
11,004,507 |
11,028,754 |
RGD:1600115 |
ENSEMBL |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
|
ISO |
12 |
11,004,507 |
11,028,754 |
RGD:1624291 |
RGD |
| G |
Ung |
uracil-DNA glycosylase |
|
|
ISO |
12 |
43,520,629 |
43,528,873 |
RGD:1624291 |
RGD |
somatic recombination of immunoglobulin genes involved in immune response
|
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
|
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:1624291 |
RGD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
|
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:1624291 |
RGD |
susceptibility to natural killer cell mediated cytotoxicity
|
| G |
Cadm1 |
cell adhesion molecule 1 |
|
|
ISO |
8 |
50,765,645 |
51,108,962 |
RGD:1624291 |
RGD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
|
ISO |
8 |
50,765,645 |
51,108,962 |
RGD:1624291 |
RGD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
|
ISS |
8 |
50,765,645 |
51,108,962 |
RGD:1600115 |
UniProtKB |
| G |
PVR |
poliovirus receptor |
|
|
ISO |
1 |
79,213,654 |
79,229,063 |
RGD:1624291 |
RGD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
|
ISO |
1 |
79,021,831 |
79,059,686 |
RGD:1624291 |
RGD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
|
IEA |
1 |
79,021,831 |
79,059,686 |
RGD:1600115 |
ENSEMBL |
susceptibility to T cell mediated cytotoxicity
|
| G |
PVR |
poliovirus receptor |
|
|
ISO |
1 |
79,213,654 |
79,229,063 |
RGD:1624291 |
RGD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
|
ISO |
1 |
79,021,831 |
79,059,686 |
RGD:1624291 |
RGD |
| G |
Pvrl2 |
poliovirus receptor-related 2 |
|
|
IEA |
1 |
79,021,831 |
79,059,686 |
RGD:1600115 |
ENSEMBL |
T cell activation involved in immune response
|
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
|
ISO |
2 |
25,886,177 |
25,899,128 |
RGD:1624291 |
RGD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
|
ISS |
2 |
25,886,177 |
25,899,128 |
RGD:1600115 |
UniProtKB |
| G |
Lcp1 |
lymphocyte cytosolic protein 1 |
|
|
ISO |
15 |
56,034,457 |
56,091,880 |
RGD:1624291 |
RGD |
| G |
Lcp1 |
lymphocyte cytosolic protein 1 |
|
|
IEA |
15 |
56,034,457 |
56,091,880 |
RGD:1600115 |
ENSEMBL |
| G |
Psen1 |
presenilin 1 |
|
|
ISO |
6 |
107,737,543 |
107,776,357 |
RGD:1624291 |
RGD |
| G |
Psen1 |
presenilin 1 |
|
|
IEA |
6 |
107,737,543 |
107,776,357 |
RGD:1600115 |
ENSEMBL |
| G |
Psen2 |
presenilin 2 |
|
|
ISO |
13 |
95,934,674 |
95,951,836 |
RGD:1624291 |
RGD |
| G |
Psen2 |
presenilin 2 |
|
|
IEA |
13 |
95,934,674 |
95,951,836 |
RGD:1600115 |
ENSEMBL |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell
|
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:1624291 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
IEA |
8 |
20,040,177 |
20,051,939 |
RGD:1600115 |
ENSEMBL |
| G |
Itgal |
integrin, alpha L |
|
|
ISO |
1 |
186,561,795 |
186,598,908 |
RGD:1624291 |
RGD |
| G |
Itgal |
integrin, alpha L |
|
|
IEA |
1 |
186,561,795 |
186,598,908 |
RGD:1600115 |
ENSEMBL |
T cell antigen processing and presentation
|
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:1624291 |
RGD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
|
IEA |
8 |
20,040,177 |
20,051,939 |
RGD:1600115 |
ENSEMBL |
T cell cytokine production
|
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
|
ISO |
11 |
70,735,283 |
70,930,374 |
RGD:1624291 |
RGD |
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
|
IEA |
11 |
70,735,283 |
70,930,374 |
RGD:1600115 |
ENSEMBL |
| G |
Slc11a1 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
|
|
ISO |
9 |
73,714,692 |
73,725,523 |
RGD:1624291 |
RGD |
| G |
Slc11a1 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
|
|
IEA |
9 |
73,714,692 |
73,725,523 |
RGD:1600115 |
ENSEMBL |
T cell differentiation involved in immune response
|
| G |
Sema4a |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
|
|
ISO |
2 |
180,552,405 |
180,570,359 |
RGD:1624291 |
RGD |
T cell homeostasis
|
| G |
Ahr |
aryl hydrocarbon receptor |
|
|
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:1624291 |
RGD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
|
IEA |
13 |
12,730,736 |
12,905,108 |
RGD:1600115 |
ENSEMBL |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
|
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:1624291 |
RGD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
|
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:1624291 |
RGD |
| G |
Casp3 |
caspase 3 |
|
|
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:1624291 |
RGD |
| G |
Ccnb2 |
cyclin B2 |
|
|
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:1624291 |
RGD |
| G |
Chst3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
|
|
ISO |
20 |
27,480,448 |
27,482,990 |
RGD:1624291 |
RGD |
| G |
Chst3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
|
|
IEA |
20 |
27,480,448 |
27,482,990 |
RGD:1600115 |
ENSEMBL |
| G |
Coro1a |
coronin, actin binding protein 1A |
|
|
ISO |
1 |
185,852,741 |
185,857,715 |
RGD:1624291 |
RGD |
| G |
Coro1a |
coronin, actin binding protein 1A |
|
|
IEA |
1 |
185,852,741 |
185,857,715 |
RGD:1600115 |
ENSEMBL |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
|
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:1624291 |
RGD |
| G |
Gimap5 |
GTPase, IMAP family member 5 |
|
|
IMP |
4 |
76,836,521 |
76,843,214 |
RGD:1303374 |
RGD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
|
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:1624291 |
RGD |
| G |
Jak3 |
Janus kinase 3 |
|
|
ISO |
16 |
18,878,139 |
18,889,441 |
RGD:1624291 |
RGD |
| G |
Jak3 |
Janus kinase 3 |
|
|
ISS |
16 |
18,878,139 |
18,889,441 |
RGD:1600115 |
BHF-UCL |
| G |
Nckap1l |
NCK associated protein 1 like |
|
|
ISO |
7 |
142,351,954 |
142,397,045 |
RGD:1624291 |
RGD |
| G |
Nckap1l |
NCK associated protein 1 like |
|
|
IEA |
7 |
142,351,954 |
142,397,045 |
RGD:1600115 |
ENSEMBL |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
|
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:1624291 |
RGD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
|
IEA |
12 |
35,074,025 |
35,117,152 |
RGD:1600115 |
ENSEMBL |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
|
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:1624291 |
RGD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
|
IEA |
18 |
62,914,845 |
62,918,832 |
RGD:1600115 |
ENSEMBL |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isozyme |
|
|
ISO |
15 |
3,986,290 |
4,030,352 |
RGD:1624291 |
RGD |
| G |
Ppp3cb |
protein phosphatase 3, catalytic subunit, beta isozyme |
|
|
IEA |
|